Unnamed: 0,title,date,stock,sentiment
421959.0,Endo Shares Fall ~10% Following Press Release From New York Governor 'Department of Financial Services Files Administrative Charges Against Endo In Connection With Its Role in the Opioid Crisis',2020-06-10 14:46:00-04:00,ENDP,negative
421960.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,ENDP,positive
421961.0,Endo International: Q1 Earnings Insights,2020-05-07 09:53:00-04:00,ENDP,neutral
421962.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,ENDP,negative
421963.0,Endo International shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-05-07 07:11:00-04:00,ENDP,positive
421964.0,Endo Withdraws FY20 Guidance,2020-05-07 06:08:00-04:00,ENDP,neutral
421965.0,"Endo International Q1 Adj. EPS $0.950 Beats $0.530 Estimate, Sales $820.405M Beat $707.650M Estimate",2020-05-07 06:08:00-04:00,ENDP,neutral
421966.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ENDP,neutral
421967.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,2020-04-23 11:27:00-04:00,ENDP,positive
421968.0,Shares of several healthcare companies are trading lower amid overall market weakness caused by the coronavirus which has decreased consumer spending and economic activity.,2020-04-15 10:05:00-04:00,ENDP,negative
421969.0,"Piper Sandler Maintains Overweight on Endo International, Lowers Price Target to $6",2020-04-15 08:43:00-04:00,ENDP,negative
421970.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,ENDP,positive
421971.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,ENDP,positive
421972.0,"Morgan Stanley Maintains Underweight on Endo International, Lowers Price Target to $3",2020-04-02 09:16:00-04:00,ENDP,negative
421973.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,ENDP,positive
421974.0,Shares of several companies in the healthcare space are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 10:18:00-04:00,ENDP,negative
421975.0,28 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-27 07:40:00-05:00,ENDP,neutral
421976.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,ENDP,negative
421977.0,24 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-26 08:01:00-05:00,ENDP,neutral
421978.0,A Peek Into The Markets: US Stock Futures Drop Ahead Of New-Home Sales Report,2020-02-26 06:29:00-05:00,ENDP,negative
421979.0,"Endo International Sees FY20 Adj. EPS $2.15-$2.40 vs $2.25 Est., Sales $2.72B-$2.92B vs $2.9B Est.",2020-02-26 06:05:00-05:00,ENDP,neutral
421980.0,"Endo International Q4 Adj. EPS $0.74 Beats $0.57 Estimate, Sales $764.8M Beat $731.43M Estimate",2020-02-26 06:04:00-05:00,ENDP,neutral
421981.0,80 Biggest Movers From Yesterday,2020-02-26 05:32:00-05:00,ENDP,neutral
421982.0,"Earnings Scheduled For February 26, 2020",2020-02-26 04:38:00-05:00,ENDP,neutral
421983.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-02-25 12:24:00-05:00,ENDP,neutral
421984.0,"Endo International shares are trading higher. Strength potentially related to opioid settlement announcement from Mallinckrodt, as Endo has also been involved in opioid litigation.",2020-02-25 08:36:00-05:00,ENDP,positive
421985.0,22 Stocks Moving in Tuesday's Pre-Market Session,2020-02-25 07:44:00-05:00,ENDP,neutral
421986.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,ENDP,neutral
421987.0,Endo Names Blaise Coleman President and Chief Executive Officer,2020-02-19 16:21:00-05:00,ENDP,neutral
421988.0,CA Ag's Office Says 'Far Along In The Process Of Talks' And Still Negotiating With Distributors On Opioid Settlement,2020-02-14 12:24:00-05:00,ENDP,neutral
421989.0,Shares of opioid-related companies are trading lower following reports suggesting 21 states have rejected an $18 billion offer to settle opioid litigation.,2020-02-14 10:15:00-05:00,ENDP,negative
421990.0,21 States Reject $18B Offer From Drug Wholesalers To Settle Opioid Litigation,2020-02-14 10:10:00-05:00,ENDP,negative
421991.0,Shares of several healthcare companies are trading higher in sympathy with the overall market after China reported the lowest number of new coronavirus cases since late January.,2020-02-12 11:05:00-05:00,ENDP,positive
421992.0,4 Specialty & Generic Drug Manufacturer Stocks Moving In Monday's After-Market Session,2020-01-27 23:48:00-05:00,ENDP,neutral
421993.0,36 Healthcare Stocks Moving In Monday's After-Market Session,2020-01-27 23:41:00-05:00,ENDP,neutral
421994.0,Endo Begins Shipment Of Authorized Generic Version Of Carafate Oral Suspension In Yhe United States,2020-01-27 16:21:00-05:00,ENDP,positive
421995.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-01-27 07:40:00-05:00,ENDP,neutral
421996.0,7 Specialty & Generic Drug Manufacturer Stocks Moving In Monday's Pre-Market Session,2020-01-27 07:36:00-05:00,ENDP,neutral
421997.0,70 Biggest Movers From Friday,2020-01-27 04:02:00-05:00,ENDP,neutral
421998.0,"Shares of several companies in the healthcare and pharmaceutical space are trading lower, not currently seeing sector-specific news. NOTE: The global spread of the Wuhan coronavirus has caused equities across to sell off.",2020-01-24 11:40:00-05:00,ENDP,neutral
421999.0,"Shares of healthcare and pharmaceutical companies are trading higher, not currently seeing any sector-specific news. NOTE: U.S. equities are trading higher ahead of today's signing of the U.S.-China phase one trade deal.",2020-01-15 11:57:00-05:00,ENDP,positive
422000.0,80 Biggest Movers From Yesterday,2020-01-15 04:48:00-05:00,ENDP,neutral
422001.0,"Endo Int'l Has Settled Opioid Probe With State of Oklahoma, To Pay State $8.75M",2020-01-10 11:51:00-05:00,ENDP,negative
422002.0,10 Biggest Price Target Changes For Friday,2020-01-03 08:31:00-05:00,ENDP,neutral
422003.0,"PiperJaffray Upgrades Endo International to Overweight, Raises Price Target to $7",2020-01-03 08:06:00-05:00,ENDP,negative
422004.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,ENDP,neutral
422005.0,18 Stocks Moving in Friday's Pre-Market Session,2020-01-03 07:31:00-05:00,ENDP,neutral
422006.0,63 Biggest Movers From Tuesday,2020-01-02 05:05:00-05:00,ENDP,neutral
422007.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-12-31 12:18:00-05:00,ENDP,neutral
422008.0,Endo International shares are trading higher. The stock dropped roughly 13% over the last 5 sessions and could be rebounding.,2019-12-31 10:30:00-05:00,ENDP,positive
422009.0,68 Biggest Movers From Yesterday,2019-12-20 04:34:00-05:00,ENDP,neutral
422010.0,46 Stocks Moving In Thursday's Mid-Day Session,2019-12-19 12:51:00-05:00,ENDP,neutral
422011.0,Endo International shares are trading higher. Not currently seeing any company-specific news. NOTE: The company has been involved in the US lawsuits against opioid makers this year and has exposure to ongoing developments in these cases.,2019-12-19 10:59:00-05:00,ENDP,positive
422012.0,Endo Launches Generic Version Of Afinitor Tablets In The United States,2019-12-10 08:06:00-05:00,ENDP,positive
422013.0,80 Biggest Movers From Yesterday,2019-12-10 05:27:00-05:00,ENDP,neutral
422014.0,48 Stocks Moving In Monday's Mid-Day Session,2019-12-09 12:26:00-05:00,ENDP,neutral
422015.0,Endo International shares are trading lower. Not seeing any news to justify the price action.,2019-12-09 11:03:00-05:00,ENDP,neutral
422016.0,75 Biggest Movers From Yesterday,2019-12-06 05:36:00-05:00,ENDP,neutral
422017.0,Endo International shares are trading lower. Not seeing any news to justify the price action.,2019-12-05 11:49:00-05:00,ENDP,neutral
422018.0,72 Biggest Movers From Yesterday,2019-12-05 05:10:00-05:00,ENDP,neutral
422019.0,Endo International shares are trading higher. Not seeing any news to justify the price action.,2019-12-04 15:21:00-05:00,ENDP,positive
422020.0,Shares of opioid-related drugmakers are trading lower on reports federal prosecutors have opened a criminal probe of opioid manufacturers.,2019-11-26 13:08:00-05:00,ENDP,negative
422021.0,63 Biggest Movers From Yesterday,2019-11-21 04:49:00-05:00,ENDP,neutral
422022.0,West Virginia Sues Opioid Makers Endo International And Mallinckrodt,2019-11-20 14:25:00-05:00,ENDP,neutral
422023.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-11-20 12:09:00-05:00,ENDP,neutral
422024.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-20 07:45:00-05:00,ENDP,neutral
422025.0,Endo International shares are trading higher after the company announced the FDA has accepted for review the original Biologics License Application for collagenase clostridium histolyticum.,2019-11-20 07:40:00-05:00,ENDP,positive
422026.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,ENDP,positive
422027.0,33 Stocks Moving in Wednesday's Pre-Market Session,2019-11-20 07:16:00-05:00,ENDP,neutral
422028.0,Endo International shares are trading higher after the company announced the FDA accepted for review the original Biologics License Application for collagenase clostridium histolyticum.,2019-11-19 16:16:00-05:00,ENDP,positive
422029.0,Endo Announces FDA Acceptance Of Original Biologics License Application For Collagenase Clostridium Histolyticum In Patients With Cellulite,2019-11-19 16:10:00-05:00,ENDP,positive
422030.0,Endo International shares are trading higher after hearing the company won a ruling to block genetic form of Adrenalin.,2019-11-15 14:22:00-05:00,ENDP,positive
422031.0,"Endo Int'l. Shares Rebound From Session Low, Still Down 0.4% For Session; Hearing Co. Won Ruling to Block Generic form Of Adrenalin",2019-11-14 10:34:00-05:00,ENDP,positive
422032.0,61 Biggest Movers From Yesterday,2019-11-06 04:19:00-05:00,ENDP,neutral
422033.0,Endo International shares are trading lower after the company reported Q3 earnings results.,2019-11-05 13:09:00-05:00,ENDP,neutral
422034.0,54 Stocks Moving In Tuesday's Mid-Day Session,2019-11-05 12:10:00-05:00,ENDP,neutral
422035.0,Endo Sees High Level Of Competition In Generics Business Driven By New Market Entrants,2019-11-05 07:50:00-05:00,ENDP,neutral
422036.0,24 Stocks Moving in Tuesday's Pre-Market Session,2019-11-05 07:23:00-05:00,ENDP,neutral
422037.0,"Earnings Scheduled For November 5, 2019",2019-11-05 04:14:00-05:00,ENDP,neutral
422038.0,"Endo Narrows FY19 Guidance: Adj. EPS From $2-$2.25 To $2.10-$2.25 vs $2.17 Estimate, Adj. EBITDA From $1.24B-$1.34B To $1.26B-$1.3B, Sales From $2.76B-$2.96B To $2.86B-$2.89B vs $2.87B Est.",2019-11-04 16:39:00-05:00,ENDP,neutral
422039.0,"Endo International Q3 EPS $0.6 Beats $0.53 Estimate, Sales $729.426M Beat $710.58M Estimate",2019-11-04 16:38:00-05:00,ENDP,neutral
422040.0,"Endo Names Paul Campanelli Chair, Will Continue To Serve As Pres, CEO",2019-11-04 16:37:00-05:00,ENDP,neutral
422041.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-10-28 08:21:00-04:00,ENDP,neutral
422042.0,Endo Int'l. Reports Presented New XIAFLEX Data At Fall Meeting Of Sexual Medicine Society Of North America,2019-10-25 07:32:00-04:00,ENDP,neutral
422043.0,Why Are Endo Shares Trading Lower?,2019-10-24 14:48:00-04:00,ENDP,neutral
422044.0,Endo International shares are trading lower after the company announced it will present data on the use of a standing MRI as compared to prone MRI for the evaluation of cellulite at the ASDS meeting.,2019-10-24 11:53:00-04:00,ENDP,neutral
422045.0,Endo To Present Data On The Use Of A Standing MRI For The Evaluation Of Cellulite At The American Society For Dermatologic Surgery Annual Meeting Oct. 24-27,2019-10-24 07:43:00-04:00,ENDP,neutral
422046.0,"Jim Cramer Gives His Take On AMD, Merck And More",2019-10-22 11:29:00-04:00,ENDP,neutral
422047.0,Endo Shares Spike 3% On Uptick In Volume Following Confirmation From Teva Of A Settlement In Track 1 Opioid Case,2019-10-21 13:55:00-04:00,ENDP,positive
422048.0,"4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain",2019-10-21 09:08:00-04:00,ENDP,negative
422049.0,Shares of opioid-related drug companies are trading lower after the WSJ reported that a settlement has been reached in the opioid addiction lawsuit. The settlement is expected to be announced today.,2019-10-21 08:55:00-04:00,ENDP,negative
422050.0,11 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-10-21 07:46:00-04:00,ENDP,neutral
422051.0,26 Stocks Moving in Monday's Pre-Market Session,2019-10-21 07:41:00-04:00,ENDP,neutral
422052.0,Endo International Gets FDA Approval for Generic Acetazolamide,2019-10-18 13:41:00-04:00,ENDP,positive
422053.0,32 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-18 08:34:00-04:00,ENDP,neutral
422054.0,27 Stocks Moving in Friday's Pre-Market Session,2019-10-18 08:29:00-04:00,ENDP,neutral
422055.0,48 Biggest Movers From Yesterday,2019-10-18 06:55:00-04:00,ENDP,neutral
422056.0,"'Market Realizing That Endp Is The Real Beneficiary Of Opioid Settlement As Reported Fundamentals Have Improved Since Stock Was At $18 A Year Ago. Low Or No Cash Payout.Good Fcf, Bal Sheet, And Strong Pipeline.  If Reporting Is True ENDP Can Be $10 On MNK' -Citron Research",2019-10-17 12:00:00-04:00,ENDP,positive
422057.0,32 Stocks Moving In Thursday's Mid-Day Session,2019-10-17 11:52:00-04:00,ENDP,neutral
422058.0,Endo International Option Alert: Fri $4.5 Calls Sweep (6) near the Ask: 607 @ $0.6 vs 420 OI; Earnings 11/5 Before Open Ref=$4.975,2019-10-17 10:46:00-04:00,ENDP,positive
422059.0,"Shares of opioid-associated drug distributors are trading higher on continued momentum after it was reported McKesson, AmerisourceBergen, and Cardinal Health are in talks to settle opioid litigation for $18 billion.",2019-10-17 09:43:00-04:00,ENDP,positive
422060.0,54 Biggest Movers From Yesterday,2019-10-17 05:52:00-04:00,ENDP,neutral
422061.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-10-16 12:35:00-04:00,ENDP,neutral
422062.0,Opioid Drug Companies Rally On Hopes of Broader Settlement,2019-10-16 11:56:00-04:00,ENDP,positive
422063.0,"Shares of opioid-associated drug distributors are trading higher after it was reported McKesson, AmerisourceBergen, and Cardinal Health are in talks to settle opioid litigation for $18 billion.",2019-10-16 08:23:00-04:00,ENDP,positive
422064.0,23 Stocks Moving in Wednesday's Pre-Market Session,2019-10-16 07:40:00-04:00,ENDP,neutral
422065.0,64 Biggest Movers From Yesterday,2019-10-15 05:07:00-04:00,ENDP,neutral
422066.0,Endo International shares are trading lower. Not seeing any news to justify the price action.,2019-10-14 14:24:00-04:00,ENDP,neutral
422067.0,Endo International shares are trading lower despite no company-specific news. This could potentially be profit taking after the stock rallied approximately 30% in the last month.,2019-10-04 10:57:00-04:00,ENDP,positive
422068.0,42 Biggest Movers From Yesterday,2019-10-04 04:36:00-04:00,ENDP,neutral
422069.0,Endo International shares are trading higher despite no company-specific news. The stock has rallied approximately 50% in the last month.,2019-10-03 14:34:00-04:00,ENDP,positive
422070.0,Sell-Side Positive On Johnson & Johnson's Unexpected Ohio Opioid Settlement,2019-10-02 15:06:00-04:00,ENDP,positive
422071.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-10-01 11:59:00-04:00,ENDP,neutral
422072.0,Endo International shares are trading higher on continued momentum after the company reported successful culmination of two legal matters regarding the unlawful compounding of vasopressin from bulk drug substances.,2019-10-01 10:24:00-04:00,ENDP,positive
422073.0,23 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-01 08:24:00-04:00,ENDP,neutral
422074.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-10-01 08:18:00-04:00,ENDP,neutral
422075.0,Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy,2019-09-30 07:36:00-04:00,ENDP,positive
422076.0,52 Biggest Movers From Friday,2019-09-30 03:39:00-04:00,ENDP,neutral
422077.0,Endo International shares are trading higher. Not seeing any news to justify the price action.,2019-09-27 10:12:00-04:00,ENDP,positive
422078.0,Endo International Receives FDA Approval For Syprine In Treatment Of Wilson's Disease,2019-09-26 14:27:00-04:00,ENDP,positive
422079.0,23 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-25 08:17:00-04:00,ENDP,neutral
422080.0,Endo International shares are trading higher despite no company-specific news. This could potentially be a rebound as the stock has dropped about 6% over the past 5 days.,2019-09-20 11:09:00-04:00,ENDP,positive
422081.0,46 Biggest Movers From Yesterday,2019-09-20 04:45:00-04:00,ENDP,neutral
422082.0,Endo International PLC shares are trading lower as traders potentially took profits after the stock increased roughly 30% in the last month.,2019-09-19 14:31:00-04:00,ENDP,positive
422083.0,Endo International PLC shares are trading higher on continued momentum the stock price increased 100% since Sep. 5th after the company announced that it submitted a biologics license application to the FDA for collagenase clostridium histolyticum.,2019-09-16 14:00:00-04:00,ENDP,positive
422084.0,Purdue Pharma Files For Bankruptcy: What You Need To Know,2019-09-16 10:58:00-04:00,ENDP,neutral
422085.0,22 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-16 08:29:00-04:00,ENDP,neutral
422086.0,24 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-13 08:44:00-04:00,ENDP,neutral
422087.0,Endo International PLC shares are trading lower. This could be a potential profit taking from investors as the stock is up approximately 46% over the past 30 days.,2019-09-12 12:22:00-04:00,ENDP,positive
422088.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-11 08:21:00-04:00,ENDP,neutral
422089.0,80 Biggest Movers From Yesterday,2019-09-11 05:11:00-04:00,ENDP,neutral
422090.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-09-10 12:19:00-04:00,ENDP,neutral
422091.0,84 Biggest Movers From Yesterday,2019-09-10 05:01:00-04:00,ENDP,neutral
422092.0,44 Stocks Moving In Monday's Mid-Day Session,2019-09-09 12:21:00-04:00,ENDP,neutral
422093.0,30 Stocks Moving in Monday's Pre-Market Session,2019-09-09 07:57:00-04:00,ENDP,neutral
422094.0,64 Biggest Movers From Friday,2019-09-09 05:43:00-04:00,ENDP,neutral
422095.0,Mid-Afternoon Market Update: Dow Up Over 100 Points; Domo Shares Tumble On Weak Forecast,2019-09-06 14:35:00-04:00,ENDP,negative
422096.0,Mid-Day Market Update: Avid Bioservices Falls Following Q1 Earnings; Endo International Shares Jump,2019-09-06 12:20:00-04:00,ENDP,positive
422097.0,46 Stocks Moving In Friday's Mid-Day Session,2019-09-06 12:09:00-04:00,ENDP,neutral
422098.0,Endo International shares are trading higher after the company announced it has submitted a biologics license application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in the buttocks.,2019-09-06 11:03:00-04:00,ENDP,positive
422099.0,Endo Announces Submission Of Biologics License Application To FDA For Collagenase Clostridium Histolyticum In Patients With Cellulite,2019-09-06 10:09:00-04:00,ENDP,neutral
422100.0,Endo International shares are trading lower after the company announced the final settlement for the Track 1 Opioid case. As part of the agreement the company will pay a total of $10 million.,2019-09-05 13:56:00-04:00,ENDP,positive
422101.0,55 Stocks Moving In Thursday's Mid-Day Session,2019-09-05 12:27:00-04:00,ENDP,neutral
422102.0,Endo Announces Execution Of Final Settlement Agreement And Release Resolving Track 1 Opioid Cases; Co. Will Pay A Total Sum Of $10M,2019-09-05 11:55:00-04:00,ENDP,positive
422103.0,Mallinckrodt Eyes Restructuring Ahead Of Cleveland Opioid Trial: 'Bankruptcy A Real Option',2019-09-05 10:39:00-04:00,ENDP,neutral
422104.0,9 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-09-05 08:15:00-04:00,ENDP,neutral
422105.0,26 Stocks Moving in Thursday's Pre-Market Session,2019-09-05 07:44:00-04:00,ENDP,neutral
422106.0,Endo Int'l. To Present New XIAFLEX Data At American Society for Surgery of the Hand's Annual Meeting,2019-09-05 07:12:00-04:00,ENDP,neutral
422107.0,"Endo International Announces Partner, Novitium Pharma, Has Received FDA Approval For Generic Orfadin",2019-09-04 07:32:00-04:00,ENDP,positive
422108.0,Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Delayed-release Tablets in the United States,2019-09-03 06:32:00-04:00,ENDP,positive
422109.0,Endo International Option Alert: Jan 17 $3 Calls Sweep (18) near the Ask: 947 @ $0.6 vs 708 OI; Ref=$2.39,2019-08-30 14:44:00-04:00,ENDP,positive
422110.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-28 08:52:00-04:00,ENDP,neutral
422111.0,30 Stocks Moving in Wednesday's Pre-Market Session,2019-08-28 08:11:00-04:00,ENDP,neutral
422112.0,64 Biggest Movers From Yesterday,2019-08-28 05:10:00-04:00,ENDP,neutral
422113.0,46 Stocks Moving In Tuesday's Mid-Day Session,2019-08-27 14:47:00-04:00,ENDP,neutral
422114.0,"Shares of several healthcare companies are trading lower after an Oklahoma Judge ruled against Johnson & Johnson in its opioid case. The case is viewed as potential precedent for 2,000 other pending suits expected to be heard in Ohio in October.",2019-08-27 12:02:00-04:00,ENDP,neutral
422115.0,12 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-27 08:24:00-04:00,ENDP,neutral
422116.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-08-27 08:05:00-04:00,ENDP,neutral
422117.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-21 08:48:00-04:00,ENDP,neutral
422118.0,55 Biggest Movers From Yesterday,2019-08-21 05:07:00-04:00,ENDP,neutral
422119.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-08-20 12:21:00-04:00,ENDP,neutral
422120.0,Mid-Morning Market Update: Markets Open Lower; Home Depot Earnings Beat Expectations,2019-08-20 10:18:00-04:00,ENDP,negative
422121.0,"Endpoint International shares are trading higher after the company announced a settlement to resolve the ""Track 1"" opioid cases. The settlement will resolve Track 1 cases which assert claims relating to manufacturing, marketing, distribution, etc.",2019-08-20 10:01:00-04:00,ENDP,positive
422122.0,Endo Announces Settlement In Principle To Resolve 'Track 1' Opioid Cases,2019-08-20 09:30:00-04:00,ENDP,positive
422123.0,72 Biggest Movers From Yesterday,2019-08-20 05:24:00-04:00,ENDP,neutral
422124.0,"Endo, Allergan in Talks to Avoid Trial Over Opioid Crisis",2019-08-20 04:38:00-04:00,ENDP,negative
422125.0,Shares of several healthcare companies are trading higher on renewed hopes of a resolution to trade tensions between the US and China.,2019-08-19 13:13:00-04:00,ENDP,positive
422126.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,ENDP,positive
422127.0,Endo International shares are trading higher on seemingly no company-specific news.,2019-08-08 13:35:00-04:00,ENDP,neutral
422128.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,ENDP,negative
422129.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,ENDP,neutral
422130.0,85 Biggest Movers From Yesterday,2019-08-07 05:39:00-04:00,ENDP,neutral
422131.0,68 Stocks Moving In Tuesday's Mid-Day Session,2019-08-06 13:55:00-04:00,ENDP,neutral
422132.0,Stocks That Broke Yearly Lows Tuesday Morning,2019-08-06 12:06:00-04:00,ENDP,negative
422133.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,ENDP,positive
422134.0,"Earnings Scheduled For August 6, 2019",2019-08-06 04:00:00-04:00,ENDP,neutral
422135.0,Endo International shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.,2019-08-05 17:09:00-04:00,ENDP,positive
422136.0,"Endo Sees FY19 Adj. EPS $2-$2.25, Sales $2.76B-$2.96B",2019-08-05 17:09:00-04:00,ENDP,neutral
422137.0,"Endo International Q2 Adj. EPS $0.52 Beats $0.48 Estimate, Sales $699.727M Beat $695.9M Estimate",2019-08-05 17:07:00-04:00,ENDP,neutral
422138.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,ENDP,negative
422139.0,Stocks That Set New 52-Week Lows Friday Morning,2019-08-02 10:46:00-04:00,ENDP,negative
422140.0,Endo Int'l. Issues Press Release Applauding US District Court Decision Vasopressin Can't Be Used For Compounding By Outsourcing Facilities,2019-08-02 06:24:00-04:00,ENDP,positive
422141.0,40 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-02 04:10:00-04:00,ENDP,neutral
422142.0,New 52-Week Lows for Tuesday Morning,2019-07-30 11:07:00-04:00,ENDP,negative
422143.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,ENDP,neutral
422144.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,ENDP,negative
422145.0,Endo International Sued By 18 States For Keeping Generic Lidoderm Off Market,2019-07-19 14:36:00-04:00,ENDP,neutral
422146.0,Option Trader Makes Bullish Bet On Lannett Rebound,2019-07-16 13:42:00-04:00,ENDP,neutral
422147.0,"Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns",2019-07-15 10:35:00-04:00,ENDP,negative
422148.0,30 Stocks Moving In Monday's Pre-Market Session,2019-07-15 08:07:00-04:00,ENDP,neutral
422149.0,"Morgan Stanley Downgrades Endo International to Underweight, Lowers Price Target to $3",2019-07-15 06:54:00-04:00,ENDP,negative
422150.0,55 Biggest Movers From Yesterday,2019-07-12 05:18:00-04:00,ENDP,neutral
422151.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-07-11 12:50:00-04:00,ENDP,neutral
422152.0,Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.,2019-07-11 10:36:00-04:00,ENDP,negative
422153.0,10 Biggest Price Target Changes For Thursday,2019-07-11 10:15:00-04:00,ENDP,neutral
422154.0,"Benzinga's Top Upgrades, Downgrades For July 11, 2019",2019-07-11 09:23:00-04:00,ENDP,positive
422155.0,"RBC Capital Downgrades Endo International to Sector Perform, Lowers Price Target to $6",2019-07-11 07:46:00-04:00,ENDP,negative
422156.0,Shares of several healthcare companies in the pharmaceutical space are trading lower after Amneal Pharmaceuticals announced a cost reduction plan in response to the continuing industry challenges. Amneal cut guidance as part of plan.,2019-07-10 11:37:00-04:00,ENDP,negative
422157.0,"Cantor Fitzgerald Comments On The Weakness In Healthcare Companies, Notes 'AMRX undertook the additional cost reduction in response to the continuing industry challenges.'; Says This Has Had Readthrough To Other Generics Names",2019-07-10 11:26:00-04:00,ENDP,negative
422158.0,60 Biggest Movers From Yesterday,2019-07-02 05:30:00-04:00,ENDP,neutral
422159.0,45 Stocks Moving In Monday's Mid-Day Session,2019-07-01 12:48:00-04:00,ENDP,neutral
422160.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Friday, June 28, 2019",2019-06-28 16:34:00-04:00,ENDP,positive
422161.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Fri., June 28, 2019",2019-06-28 13:42:00-04:00,ENDP,positive
422162.0,Shares of multiple drugmakers and biotech companies are trading higher after AbbVie announced it will acquire Allergan.,2019-06-25 11:21:00-04:00,ENDP,positive
422163.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-06-25 08:04:00-04:00,ENDP,neutral
422164.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,ENDP,neutral
422165.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Thur., June 20, 2019",2019-06-20 14:25:00-04:00,ENDP,positive
422166.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Wed., June 19, 2019",2019-06-19 13:06:00-04:00,ENDP,positive
422167.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Tue., June 18, 2019",2019-06-18 13:19:00-04:00,ENDP,positive
422168.0,"Nevakar Reports Entered $50M Product Financing Deal With Affiliate Of NovaQuest Capital; Nevakar To Develop, Seek FDA Approval With Endo Int'l.'s Endo Ventures Subsidiary",2019-06-18 08:12:00-04:00,ENDP,positive
422169.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,ENDP,neutral
422170.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Mon., June 17, 2019",2019-06-17 13:43:00-04:00,ENDP,positive
422171.0,10 Biggest Price Target Changes For Monday,2019-06-17 09:58:00-04:00,ENDP,neutral
422172.0,"Benzinga's Top Upgrades, Downgrades For June 17, 2019",2019-06-17 09:10:00-04:00,ENDP,positive
422173.0,28 Stocks Moving In Monday's Pre-Market Session,2019-06-17 08:06:00-04:00,ENDP,neutral
422174.0,"Citi Downgrades Endo International to Neutral, Lowers Price Target to $5",2019-06-17 06:55:00-04:00,ENDP,negative
422175.0,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",2019-06-12 07:34:00-04:00,ENDP,neutral
422176.0,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering",2019-06-11 07:34:00-04:00,ENDP,positive
422177.0,"Barclays Initiates Coverage On Endo International with Equal-Weight Rating, Announces $6 Price Target",2019-06-11 07:17:00-04:00,ENDP,neutral
422178.0,"The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation",2019-05-29 07:38:00-04:00,ENDP,neutral
422179.0,Endo Int'l. Reports Data From Phase 3 Study Of Collagenase Clostridium Histolyticum For Treatment Of Cellulite Will Be Presented At  The Aesthetic Meeting 2019,2019-05-17 07:04:00-04:00,ENDP,neutral
422180.0,50 Biggest Movers From Yesterday,2019-05-14 05:39:00-04:00,ENDP,neutral
422181.0,Mid-Afternoon Market Update: Amber Road Surges On Acquisition News; FutureFuel Shares Slide,2019-05-13 14:53:00-04:00,ENDP,positive
422182.0,42 Stocks Moving In Monday's Mid-Day Session,2019-05-13 12:48:00-04:00,ENDP,neutral
422183.0,Mid-Day Market Update: Dow Down Over 600 Points; INSYS Therapeutics Shares Plummet,2019-05-13 12:09:00-04:00,ENDP,positive
422184.0,"Benzinga's Top Upgrades, Downgrades For May 13, 2019",2019-05-13 09:18:00-04:00,ENDP,positive
422185.0,Endo International shares are trading lower after JP Morgan downgraded the stock from Neutral to Underweight and announced a $9 price target.,2019-05-13 08:55:00-04:00,ENDP,positive
422186.0,"JP Morgan Downgrades Endo International plc - Ordinary Shares to Underweight, Announces $9 Price Target",2019-05-13 07:39:00-04:00,ENDP,positive
422187.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,ENDP,neutral
422188.0,"A Peek Into The Markets: US Stock Futures Dip Ahead Of Economic Data, Fed Speakers",2019-05-09 06:43:00-04:00,ENDP,neutral
422189.0,"Endo International Q1 EPS $0.53 Beats $0.43 Estimate, Sales $720.411M Beat $691.82M Estimate; Reaffirms FY19, FY20, 5-Year Goals",2019-05-09 06:34:00-04:00,ENDP,neutral
422190.0,Endo Int'l. Reaffirms FY19 Guidance,2019-05-09 06:33:00-04:00,ENDP,neutral
422191.0,"Endo International Q1 EPS $0.53 Beats $0.43 Estimate, Sales $720.411M Beat $691.82M Estimate",2019-05-09 06:32:00-04:00,ENDP,neutral
422192.0,"Earnings Scheduled For May 9, 2019",2019-05-09 04:07:00-04:00,ENDP,neutral
422193.0,Endo Int'l. Reports Its Par Pharma Unit Is Voluntarily Recalling 1 Lot Of Mycophenolate Mofetil For Injection,2019-05-01 18:31:00-04:00,ENDP,neutral
422194.0,Endo Int'l. Reports Began Shipping Authorized Generic Version Of PROVENTIL HFA Inhalation Aerosol In US,2019-04-05 07:33:00-04:00,ENDP,neutral
422195.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-04-03 08:04:00-04:00,ENDP,neutral
422196.0,Endo Int'l. Shares Volatile Here Amid Report Co. Has won A Ruling Reviving Patent On Opana Extended-Release Drug,2019-03-28 09:49:00-04:00,ENDP,positive
422197.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-03-26 13:20:00-04:00,ENDP,neutral
422198.0,"Benzinga's Top Upgrades, Downgrades For March 20, 2019",2019-03-20 09:12:00-04:00,ENDP,positive
422199.0,"SunTrust Robinson Humphrey Initiates Coverage On Endo International with Buy Rating, Announces $13 Price Target",2019-03-20 07:18:00-04:00,ENDP,neutral
422200.0,Endo Highlights Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery,2019-03-19 07:31:00-04:00,ENDP,neutral
422201.0,"OxyContin Maker Purdue Pharma's Legal Entanglement, Explained",2019-03-05 11:16:00-05:00,ENDP,positive
422202.0,SVB Leerink Downgrades Endo International to Market Perform,2019-03-05 09:48:00-05:00,ENDP,neutral
422203.0,62 Biggest Movers From Yesterday,2019-03-05 05:19:00-05:00,ENDP,neutral
422204.0,50 Stocks Moving In Monday's Mid-Day Session,2019-03-04 12:44:00-05:00,ENDP,neutral
422205.0,Endo International PLC shares are trading lower after the company announced that the FDA has determined not to include Vasopressin on the 503B Bulks list.,2019-03-04 12:32:00-05:00,ENDP,positive
422206.0,"UPDATE: FDA Has Determined There Is No Clinical Need To Compound Vasopressin And As A Result, It Will Be Unlawful For Compounding Facilities To Sell Vasopressin Products Unless They Manufacture Them Using An FDA-Approved Product",2019-03-01 15:32:00-05:00,ENDP,positive
422207.0,Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List,2019-03-01 15:28:00-05:00,ENDP,neutral
422208.0,Endo Int'l. Says Will Showcase Late-Breaking Phase 3 CCH Data At AAD Annual Meeting,2019-03-01 07:32:00-05:00,ENDP,neutral
422209.0,75 Biggest Movers From Yesterday,2019-03-01 04:55:00-05:00,ENDP,neutral
422210.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-02-28 12:28:00-05:00,ENDP,neutral
422211.0,"Endo International shares are trading higher after the company reported better-than-expected Q4 EPS and sales results, offsetting weak FY19 EPS guidance.",2019-02-28 11:26:00-05:00,ENDP,negative
422212.0,34 Stocks Moving In Thursday's Pre-Market Session,2019-02-28 08:26:00-05:00,ENDP,neutral
422213.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,ENDP,positive
422214.0,"Endo International Sees FY19 Adj. EPS $2.00-$2.25 vs $2.66 Est., Sales $2.75B-$2.96B vs $2.92B Est.",2019-02-28 06:48:00-05:00,ENDP,neutral
422215.0,"Endo International Q4 EPS $0.75 Beats $0.59 Estimate, Sales $786.39M Beat $738.77M Estimate",2019-02-28 06:47:00-05:00,ENDP,neutral
422216.0,"Earnings Scheduled For February 28, 2019",2019-02-28 04:08:00-05:00,ENDP,neutral
422217.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,ENDP,neutral
422218.0,Endo Agrees Not To Oppose Additional Stay Of FDA Litigation Following Restoration Of Government Appropriations,2019-02-07 08:04:00-05:00,ENDP,neutral
422219.0,Traders Circulate Documents Appearing To Sho Endo vs FDA Litigation Will Be Stayed Until Shutdown Ends,2019-01-07 17:01:00-05:00,ENDP,negative
422220.0,Endo Int'l. Reports FDA Has Requested Further Stay Of Co.'s Ongoing Litigation Against FDA For Duration Of Shutdown,2018-12-31 07:32:00-05:00,ENDP,negative
422221.0,Catalyst Pharmaceuticals Announces Definitive Agreement With Endo For Vigabatrin Tablets,2018-12-18 11:40:00-05:00,ENDP,positive
422222.0,Endo International Drops Ahead Of '60 Minutes' Opioid Segment,2018-12-14 17:01:00-05:00,ENDP,neutral
422223.0,Endo International Option Alert: Apr 18 $9 Puts at the Bid: 2750 @ $1.0 vs 115 OI; Ref=$10.27,2018-12-14 14:42:00-05:00,ENDP,positive
422224.0,"Endo Int'l. Shares Fall ~1.8% As Traders Circulate CBS News Article Previewing '60 Minutes' Report On Sun., Dec. 16 'The Man Who Took On Big Tobacco Takes Aim At Opioids'",2018-12-14 13:33:00-05:00,ENDP,positive
422225.0,"Benzinga's Top Upgrades, Downgrades For November 9, 2018",2018-11-09 09:02:00-05:00,ENDP,positive
422226.0,"Canaccord Genuity Upgrades Endo International to Buy, Announces $20 Price Target",2018-11-09 06:27:00-05:00,ENDP,neutral
422227.0,80 Biggest Movers From Yesterday,2018-11-09 05:18:00-05:00,ENDP,neutral
422228.0,65 Stocks Moving In Thursday's Mid-Day Session,2018-11-08 12:51:00-05:00,ENDP,neutral
422229.0,"Endo Health Sees FY18 Adj. EPS $2.65-$2.75 vs $2.60 Estimate, Sales $2.87B-$2.92B vs $2.81B Est.",2018-11-08 08:54:00-05:00,ENDP,neutral
422230.0,"Endo Health Solutions Inc. Q3 EPS $0.71 Beats $0.59 Estimate, Sales $745.466M Beat $696.31M Estimate",2018-11-08 08:54:00-05:00,ENDP,positive
422231.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,ENDP,negative
422232.0,"Earnings Scheduled For November 8, 2018",2018-11-08 04:00:00-05:00,ENDP,neutral
422233.0,Q3 Earnings Preview For Endo,2018-11-07 13:30:00-05:00,ENDP,neutral
422234.0,Endo International  Announces Phase 3 Studies Of Collagenase Clostridium Histolyticum In Patients With Cellulite Showed Statistical Significant Levels Of Improvement In Cellulite Severity; RELEASE-1 Met 8 Of 8 Key Secondary Endpoints And Release 2 Met 7,2018-11-07 08:19:00-05:00,ENDP,positive
422235.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,ENDP,neutral
422236.0,"Akorn Upgraded By Piper Jaffray On Improved Cost Structure, Product Potential",2018-10-17 09:41:00-04:00,ENDP,positive
422237.0,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",2018-10-17 08:15:00-04:00,ENDP,negative
422238.0,"Stocks Which Set New 52-Week High Yesterday, October 10th",2018-10-11 09:08:00-04:00,ENDP,neutral
422239.0,"Stocks Which Set New 52-Week High Yesterday, October 3rd",2018-10-04 11:18:00-04:00,ENDP,neutral
422240.0,Endo Int'l. Reports Voluntary Nationwide Recall Of 2 Lots Of Robaxin 750mg Tablets 100 Count Bottle Packs Due To Incorrect Daily Dosing Info On Label,2018-09-28 08:32:00-04:00,ENDP,neutral
422241.0,Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End,2018-09-24 06:08:00-04:00,ENDP,positive
422242.0,"Goldman's Specialty Pharma Pair Trade: Sidelined On Endo, Bearish On Mallinckrodt",2018-09-11 18:15:00-04:00,ENDP,neutral
422243.0,"Goldman Sachs Upgrades Endo International to Neutral, Raises Price Target to $15",2018-09-11 08:34:00-04:00,ENDP,neutral
422244.0,"Jim Cramer Weighs In On CarMax, AbbVie And More",2018-09-07 07:37:00-04:00,ENDP,neutral
422245.0,"Seeing Social Media Mention That Endo Is Seeking Separate Settlement To End Opioid Lawsuits, Unconfirmed",2018-09-06 14:56:00-04:00,ENDP,negative
422246.0,"Stocks Which Set New 52-Week High Yesterday, September 4th",2018-09-05 10:22:00-04:00,ENDP,neutral
422247.0,Endo Shares Spike Higher As Reuters Reports That The FDA Is Proposing To Restrict Compounding Of Endo's Vasostrict,2018-08-27 12:47:00-04:00,ENDP,negative
422248.0,Endo Lifts Temporary Stay Of FDA Litigation Following Launch Of A Bulk-Compounded Vasopressin Product By A Section 503B Outsourcing Facility,2018-08-15 06:01:00-04:00,ENDP,negative
422249.0,"Benzinga's Top Upgrades, Downgrades For August 13, 2018",2018-08-13 09:04:00-04:00,ENDP,positive
422250.0,RBC Capital Upgrades Endo International to Outperform,2018-08-13 07:46:00-04:00,ENDP,neutral
422251.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Aug. 9, 2018",2018-08-09 11:18:00-04:00,ENDP,positive
422252.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,ENDP,neutral
422253.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,ENDP,positive
422254.0,85 Biggest Movers From Yesterday,2018-08-09 05:15:00-04:00,ENDP,neutral
422255.0,Endo Int'l Filing Shows Registration For Mixed Securities Shelf Offering,2018-08-08 16:25:00-04:00,ENDP,positive
422256.0,Mid-Afternoon Market Update: Crude Oil Down 3.5%; Endo International Shares Surge After Strong Q2 Results,2018-08-08 14:32:00-04:00,ENDP,positive
422257.0,68 Stocks Moving In Wednesday's Mid-Day Session,2018-08-08 12:30:00-04:00,ENDP,neutral
422258.0,Mid-Day Market Update: 3D Systems Climbs On Earnings Beat; Core Molding Technologies Shares Drop,2018-08-08 12:07:00-04:00,ENDP,neutral
422259.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,ENDP,neutral
422260.0,"Endo International shares are up 19.5% after the company beat Q2 earnings estimates, raised 2018 sales guidance and issued strong 2018 EPS guidance.",2018-08-08 10:24:00-04:00,ENDP,positive
422261.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,ENDP,positive
422262.0,40 Stocks Moving In Wednesday's Pre-Market Session,2018-08-08 08:08:00-04:00,ENDP,neutral
422263.0,"Endo Int'l. Nevakar Report Exclusive Licensing Deal For Development Of 5 Differentiated, Sterile Injectable Products In US, Canada, No Terms Disclosed",2018-08-08 07:20:00-04:00,ENDP,negative
422264.0,"Endo Sees Fy18 Sales $2.75-$2.85B vs $2.75B Est., EPS $2.50-$2.60 vs $2.42 Est.",2018-08-08 07:07:00-04:00,ENDP,neutral
422265.0,"Endo International Q2 EPS $0.76 Beats $0.54 Estimate, Sales $714.696M Beat $678.35M Estimate",2018-08-08 07:06:00-04:00,ENDP,neutral
422266.0,"Earnings Scheduled For August 8, 2018",2018-08-08 06:03:00-04:00,ENDP,neutral
422267.0,Earnings Preview: Endo International,2018-08-07 14:52:00-04:00,ENDP,neutral
422268.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,ENDP,neutral
422269.0,"Stocks Which Set New 52-Week High Yesterday, July 31",2018-08-01 12:04:00-04:00,ENDP,neutral
422270.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,ENDP,negative
422271.0,"Stocks Which Set New 52-Week High Yesterday, July 30th",2018-07-31 09:20:00-04:00,ENDP,neutral
422272.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,ENDP,neutral
422273.0,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",2018-07-27 08:44:00-04:00,ENDP,neutral
422274.0,Endo Int'l. Reports Par Pharma Has Begun Shipping Authorized Generic Version Of Merck's INVANZ,2018-07-27 07:31:00-04:00,ENDP,neutral
422275.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,ENDP,negative
422276.0,"Endo, Bayer Defeat Appeal By Custopharm Over Validity Of Patents Related To Testosterone Replacement Therapy Aveed, Says They Admitted To Infringement, Failed To PRove That Endo's And Bayer's Claims Were Invalid",2018-07-13 10:00:00-04:00,ENDP,negative
422277.0,"Endo Begins Shipment Of Authorized Generic Version Of Takeda's Colcrys (colchicine, USP) In United States For Prophylaxis",2018-07-02 07:33:00-04:00,ENDP,positive
422278.0,"Endo Wins Citi Upgrade On Positive Catalysts, Cellulite Treatment Opportunity",2018-06-27 15:41:00-04:00,ENDP,positive
422279.0,"Benzinga's Top Upgrades, Downgrades For June 27, 2018",2018-06-27 10:14:00-04:00,ENDP,positive
422280.0,Citigroup Upgrades Endo International to Buy,2018-06-27 08:10:00-04:00,ENDP,neutral
422281.0,Endo International Option Alert: Jan 18 $7.5 Puts at the Ask: 1750 @ $0.95 vs 22021 OI; Earnings 8/7 Before Open [est] Ref=$9.51,2018-06-20 14:32:00-04:00,ENDP,positive
422282.0,Endo  Option Alert: Jun 29 $9 Calls Sweep (29) at the Ask: 1353 @ $0.5 vs 0 OI; Earnings 8/7 Before Open [est] Ref=$8.83,2018-06-13 10:03:00-04:00,ENDP,positive
422283.0,Endo International Option Alert: Jun 22 $8.5 Calls Sweep (5) near the Ask: 1340 @ $0.401 vs 81 OI; Earnings 8/7 Before Open [est] Ref=$8.32,2018-06-12 09:53:00-04:00,ENDP,positive
422284.0,"Endo Announces Master Settlement Agreement Allowing for Resolution Of All Known Testosterone Replacement Therapy Product Liability Claims 
Against Co.",2018-06-11 15:22:00-04:00,ENDP,positive
422285.0,40 Biggest Movers From Yesterday,2018-06-07 04:50:00-04:00,ENDP,neutral
422286.0,Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching,2018-05-19 16:10:00-04:00,ENDP,positive
422287.0,"Endo International Q1 EPS $0.67 Beats $0.54 Estimate, Sales $700.52M Beat $689.21M Estimate",2018-05-08 06:33:00-04:00,ENDP,neutral
422288.0,"Earnings Scheduled For May 8, 2018",2018-05-08 04:38:00-04:00,ENDP,neutral
422289.0,"Lannett Acquires a Portfolio of Generic Drugs from Endo International, Terms Not Disclosed",2018-05-07 07:02:00-04:00,ENDP,neutral
422290.0,24 Stocks Moving In Wednesday's Pre-Market Session,2018-04-18 08:02:00-04:00,ENDP,neutral
422291.0,"Endo Int'l Receives Notification Eagle Pharma Has Submitted ANDA to FDA Seeking Approval For A Generic Version of Vasostrict; Endo Says It Intends to 'Vigorously Protect Its Intellectual Property,' Including Potentially Filing Patent Infringement Lawsuit",2018-04-17 16:34:00-04:00,ENDP,positive
422292.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-04-04 12:50:00-04:00,ENDP,neutral
422293.0,"Benzinga's Top Upgrades, Downgrades For April 4, 2018",2018-04-04 09:45:00-04:00,ENDP,positive
422294.0,"The Market In 5 Minutes: China Tariffs, Zuckerberg, Spotify, Model 3 Deliveries And More",2018-04-04 09:00:00-04:00,ENDP,neutral
422295.0,"A Peek Into The Markets: US Stock Futures Signal Lower Start, Dow Futures Down 450 Points",2018-04-04 07:45:00-04:00,ENDP,negative
422296.0,Mizuho Downgrades Endo International to Neutral,2018-04-04 06:47:00-04:00,ENDP,neutral
422297.0,Endo Agrees to Extend Temporary Stay of Litigation Against the FDA,2018-04-02 07:31:00-04:00,ENDP,positive
422298.0,Zacks: 3 Drug Stocks To Avoid For Now,2018-03-27 11:33:00-04:00,ENDP,negative
422299.0,33 Biggest Movers From Yesterday,2018-03-21 05:30:00-04:00,ENDP,neutral
422300.0,30 Stocks Moving In Friday's Pre-Market Session,2018-03-02 08:09:00-05:00,ENDP,neutral
422301.0,Endo Late Thursday Obtained Preliminary Injunction Against QuVa Pharma Preventing Marketing and Release of Vasopressin Product,2018-03-02 07:50:00-05:00,ENDP,neutral
422302.0,Gabelli & Co. Downgrades Endo International to Hold,2018-02-28 08:56:00-05:00,ENDP,neutral
422303.0,"Endo Sees FY18 Sales $2.6-$2.8B vs $3.03B Est., EPS $2.15-$2.55 vs $2.86 Est.",2018-02-27 06:09:00-05:00,ENDP,neutral
422304.0,"Endo Reports Q4 EPS $0.77 vs $0.61 Est., Sales $768.64M vs $760M Est.",2018-02-27 06:08:00-05:00,ENDP,neutral
422305.0,"Earnings Scheduled For February 27, 2018",2018-02-27 04:01:00-05:00,ENDP,neutral
422306.0,28 Stocks Moving In Monday's Mid-Day Session,2018-02-26 12:25:00-05:00,ENDP,neutral
422307.0,"Benzinga's Top Upgrades, Downgrades For February 26, 2018",2018-02-26 09:51:00-05:00,ENDP,positive
422308.0,JMP Securities Downgrades Endo International to Market Perform,2018-02-26 07:46:00-05:00,ENDP,positive
422309.0,Endo Int'l. Reports Initiation Of 2 Pivotal Phase 3 Trials Of Collagenase Clostridium Histolyticum For Treatment Of Cellulite,2018-02-06 07:35:00-05:00,ENDP,neutral
422310.0,Trump Says He'll Be Tough With Drug Companies On Opioid Addiction,2018-01-29 11:39:00-05:00,ENDP,negative
422311.0,Endo Agrees to FDA's Request to Seek Temporary Litigation Stay,2018-01-24 17:05:00-05:00,ENDP,neutral
422312.0,33 Stocks Moving In Thursday's Mid-Day Session,2018-01-18 12:24:00-05:00,ENDP,neutral
422313.0,"Traders Attributing Weakness In Endo Int'l., Teva, Mylan To Earlier NY Times Article 'Fed Up With Drug Companies, Hospitals Decide to Start Their Own'",2018-01-18 10:05:00-05:00,ENDP,negative
422314.0,"Ohio Attorney General Says State Is Hoping To Begin Opioid Settlement Talks With Endo, Allergan",2018-01-11 13:51:00-05:00,ENDP,positive
422315.0,"Cantor Out With Note On Endo, Says Oxymorphone Subpoena May Not Hurt That Much And Is Isolated To Endo For Now, But More Co.'s Could Be The Target To Investigations Over Time Including Teva, Mylan, Impax, Mallinckrodt, Allergan",2018-01-11 11:18:00-05:00,ENDP,positive
422316.0,Endo International Announces It Has Received A Grand Jury Subpoena From U.S. Attorney's Office For Southern District Of Florida Relating To Products Containing Oxymorphone,2018-01-11 08:34:00-05:00,ENDP,positive
422317.0,"Opioid Drug Cos. Showing Strength Wednesday; ENDP +8.83%, INSY +17.17%, KMPH +9.64%",2018-01-03 15:01:00-05:00,ENDP,positive
422318.0,5 Biggest Price Target Changes For Wednesday,2018-01-03 09:52:00-05:00,ENDP,neutral
422319.0,"Leerink Swann Initiates Coverage On Endo International with Outperform Rating, Announces $12.00 Price Target",2018-01-03 08:38:00-05:00,ENDP,neutral
422320.0,"Earlier Chicago Tribune Report Detailed 5 Illinois Counties Suing Drug Cos. Over Opioid Abuses; Shares Of Cos. Mentioned Seem Largely Unaffected: TEVA +5.3%, ABT -0.33%, JNJ +0.03%, ENDP +0.12%",2017-12-21 14:42:00-05:00,ENDP,negative
422321.0,13G Filing Shows Glenview Capital Reporting 6.7% Stake In Endo International,2017-11-13 16:53:00-05:00,ENDP,neutral
422322.0,28 Stocks Moving In Monday's Pre-Market Session,2017-11-13 08:06:00-05:00,ENDP,neutral
422323.0,44 Biggest Movers From Friday,2017-11-13 05:41:00-05:00,ENDP,neutral
422324.0,Endo Higher After Q3 Beat,2017-11-10 13:36:00-05:00,ENDP,neutral
422325.0,35 Stocks Moving In Friday's Mid-Day Session,2017-11-10 12:41:00-05:00,ENDP,neutral
422326.0,31 Stocks Moving In Friday's Pre-Market Session,2017-11-10 08:19:00-05:00,ENDP,neutral
422327.0,"Endo Sees FY17 Sales $3.38-$3.53B vs $3.47B Est., EPS $3.35-$3.65 vs $3.52 Est.",2017-11-09 16:03:00-05:00,ENDP,neutral
422328.0,"Endo Reports Q3 EPS $0.91 vs $0.67 Est., Sales $786.88M vs $784M Est.",2017-11-09 16:02:00-05:00,ENDP,neutral
422329.0,"Earnings Scheduled For November 9, 2017",2017-11-09 04:08:00-05:00,ENDP,neutral
422330.0,"Endo Int'l Shares Retake Mon. Morning Highs, Up 10.4% Tues.; Stock Did Not React To Report State Attorney Generals Have Expanded Suit Alleging Price Fixing By Generic Drugmakers; Co. Issued Strong Guidance Mon. Morning",2017-10-31 10:50:00-04:00,ENDP,positive
422331.0,"Watching Healthcare, Biotech Stocks, ETFs Amid Report Attorney Generals From 46 States Will Expand Suit Related To Alleged Price Fixing Among Generic Drugmakers to 18 Cos., 15 Medicines",2017-10-31 10:46:00-04:00,ENDP,positive
422332.0,Endo International Piques Investor Interest After Raising Guidance,2017-10-30 13:03:00-04:00,ENDP,positive
422333.0,35 Stocks Moving In Monday's Mid-Day Session,2017-10-30 12:30:00-04:00,ENDP,neutral
422334.0,"Endo Sees Q3 Sales Of ~$785M vs $784M Est., Adj. EPS $0.85 vs $0.66 Est., FY17 Sales $3.38B-$3.53B vs $3.47B Est., EPS $3.35-$3.65 vs $3.52 Est.",2017-10-30 08:32:00-04:00,ENDP,neutral
422335.0,"Endo Int'l. Reports Filing Of Federal Suit To Obtain FDA Compliance With Drug Quality, Security Act Of 2013",2017-10-26 16:46:00-04:00,ENDP,positive
422336.0,Federal Prosecutors In Conneticut Began A Criminal Investigation Into Purdue Pharma,2017-10-25 12:48:00-04:00,ENDP,negative
422337.0,"FDA Says It Sent Letters To 74 Manufacturers Of Opioid Analgesics Intended For Outpatient Use, Will Soon Issue Guidance For Applicants Seeking Approval For Generic Versions Of Abuse-Deterrent Opioids",2017-09-28 15:03:00-04:00,ENDP,positive
422338.0,18 Biggest Mid-Day Losers For Thursday,2017-09-28 13:09:00-04:00,ENDP,negative
422339.0,"Benzinga's Top Upgrades, Downgrades For September 28, 2017",2017-09-28 09:08:00-04:00,ENDP,positive
422340.0,"Goldman Sachs Initiates Coverage On Endo International plc - Ordinary Shares with Sell Rating, Announces $7.00 Price Target",2017-09-28 07:54:00-04:00,ENDP,positive
422341.0,"UPDATE: NY AG Schneiderman Served Subpoenas To Endo Int'l, J&J's Janssen Pharma, Teva, Allergan",2017-09-19 12:35:00-04:00,ENDP,neutral
422342.0,"New Mexico Said To Be Suing Johnson & Johnson, Endo, Teva, Allergan & Others Over Their Role In Opioid Drug Epidemic",2017-09-07 15:05:00-04:00,ENDP,negative
422343.0,"No Pain, No Gain: How The American Military Wants Big Pharma To Cure The Opioid Crisis",2017-08-20 10:23:00-04:00,ENDP,negative
422344.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-08-08 08:06:00-04:00,ENDP,neutral
422345.0,"Endo International Sees FY 2017 EPS $3.35 to $3.65 vs $3.53 Est., Slaes $3.38B to $3.53B vs $3.49B Est.",2017-08-08 07:48:00-04:00,ENDP,neutral
422346.0,"Endo International Q2 Adj. EPS $0.93 vs $0.73 Est., Sales $876M vs $836M Est.",2017-08-08 07:47:00-04:00,ENDP,neutral
422347.0,"Earnings Scheduled For August 8, 2017",2017-08-08 04:35:00-04:00,ENDP,neutral
422348.0,"Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims, Will Increase Liability Accrual By $775M",2017-08-07 16:34:00-04:00,ENDP,positive
422349.0,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 11:55:00-04:00,ENDP,neutral
422350.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-08-02 08:14:00-04:00,ENDP,neutral
422351.0,22 Stocks Moving In Tuesday's Pre-Market Session,2017-08-01 08:04:00-04:00,ENDP,neutral
422352.0,UPDATE: Endo Sees Realizing ~$55M-$65M In Annual Net Run Rate Pre-Tax Cost Savings By Q4'18,2017-07-21 08:33:00-04:00,ENDP,neutral
422353.0,"UPDATE: Endo Sees Restructuring Actions To Reduce Co.'s Workforce By ~875 Positions, Result In Pre-Tax Charge Of ~$325M",2017-07-21 08:32:00-04:00,ENDP,neutral
422354.0,"UPDATE: Endo Will Cease Operations, Close Manufacturing, Distribution Facilities In Huntsville, Alabama",2017-07-21 08:31:00-04:00,ENDP,neutral
422355.0,Endo Int'l Reports Will Restructure Its Manufacturing Network,2017-07-21 08:31:00-04:00,ENDP,neutral
422356.0,22 Stocks Moving In Friday's Pre-Market Session,2017-07-21 08:12:00-04:00,ENDP,neutral
422357.0,22 Stocks Moving In Monday's Pre-Market Session,2017-07-10 08:24:00-04:00,ENDP,neutral
422358.0,"UPDATE: Endo Says It Remains Confident In Its Research Demonstrating The Safety And Efficacy Of OPANA ER, Following Withdrawal Of OPANA",2017-07-06 12:18:00-04:00,ENDP,positive
422359.0,"Endo Provides Update On OPANA ER, Company Says It Will Voluntarily Remove OPANA ER From The Market; Will Incur Pretax Impairment Charge Of ~$20M",2017-07-06 12:15:00-04:00,ENDP,neutral
422360.0,How Have The Best And Worst Stocks Of 2016 Performed In 2017?,2017-07-05 14:49:00-04:00,ENDP,neutral
422361.0,Endo Announces Sale of Grupo Farmaceutico SOMAR for $124M,2017-07-05 07:31:00-04:00,ENDP,neutral
422362.0,"Imprimis Spins Off Eton Pharmaceuticals To Challenge Pricey Pipelines Of Mallinckrodt, Endo",2017-06-20 16:05:00-04:00,ENDP,positive
422363.0,"UPDATE: Imprimis CEO Mark Baum Tells Benzinga Eton Spin-Off Will Respond To FDA Pharma Competition Concerns, Improve Competition Against 2 'Expensive drugs without competition: Mallinckrodt's H.P. Acthar gel and Endo's Xiaflex'",2017-06-20 16:02:00-04:00,ENDP,positive
422364.0,"Cantor Fitzgerald Initiates Coverage On Endo International plc - Ordinary Shares with Neutral Rating, Announces $12.00 Price Target",2017-06-16 06:23:00-04:00,ENDP,positive
422366.0,Alkermes Looks To Capitalize On Opioid Epidemic Through Aggressive Lobbying,2017-06-12 12:00:00-04:00,ENDP,negative
422368.0,"Stocks To Watch For June 12, 2017",2017-06-12 05:23:00-04:00,ENDP,neutral
422369.0,Mid-Afternoon Market Update: NASDAQ Down 2.5%; DuPont Fabros Shares Spike Higher,2017-06-09 14:56:00-04:00,ENDP,positive
422370.0,15 Biggest Mid-Day Losers For Friday,2017-06-09 13:13:00-04:00,ENDP,negative
422371.0,Mid-Day Market Update: Dow Surges 100 Points; Endo International Shares Plummet,2017-06-09 12:18:00-04:00,ENDP,positive
422372.0,Endo To Enter A Year Of Recovery Following FDA Request To Pull Opana ER Off The Market,2017-06-09 09:49:00-04:00,ENDP,neutral
422373.0,"Benzinga's Top Upgrades, Downgrades For June 9, 2017",2017-06-09 09:26:00-04:00,ENDP,positive
422375.0,20 Stocks Moving In Friday's Pre-Market Session,2017-06-09 08:03:00-04:00,ENDP,neutral
422376.0,Stifel Nicolaus Downgrades Endo International plc - Ordinary Shares to Hold,2017-06-09 07:17:00-04:00,ENDP,positive
422377.0,Endo Responds To FDA Request To Voluntarily Withdraw OPANA ER From The Market; Co. Is Reviewing Request And Evaluating Its Options,2017-06-08 17:56:00-04:00,ENDP,neutral
422378.0,"Endo Shares Lower, FDA Has Reportedly Requested Removal Of OPANA ER For Risks Related To Abuse",2017-06-08 16:20:00-04:00,ENDP,negative
422379.0,15 Biggest Mid-Day Gainers For Thursday,2017-06-08 12:28:00-04:00,ENDP,neutral
422380.0,Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation,2017-06-07 17:14:00-04:00,ENDP,neutral
422382.0,Veloxis Pharma Announces Deal with Endo's Paladin Labs for Commercialization of Envarsus XR in Canada,2017-06-06 15:02:00-04:00,ENDP,neutral
422383.0,"Veloxis Pharmaceuticals, Endo Ventures Announce Agreement for Paladin Labs to Commercialize Envarsus XR in Canada",2017-06-05 04:20:00-04:00,ENDP,positive
422384.0,States Are Firing Back At Opioid Drug Producers,2017-06-01 10:48:00-04:00,ENDP,negative
422385.0,"Shares Of Johnons & Johnson, Teva Pharma, Endo Int'l, And Allergan All Higher Today Despite News State Of Ohio Has Sued These Companies For Alleged Role In Opioid Epidemic",2017-05-31 12:59:00-04:00,ENDP,positive
422386.0,How Much The Opioid Epidemic Actually Costs The Non-User,2017-05-28 15:15:00-04:00,ENDP,neutral
422387.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2017-05-23 05:01:00-04:00,ENDP,positive
422388.0,Benzinga's Option Alert Recap From May 22,2017-05-22 16:39:00-04:00,ENDP,positive
422389.0,Option Alert: Endo Jul 15.0 Calls Sweep: 600 @  ASK  $0.30: 1532 traded vs 3166 OI:  Earnings 8/8 Before Open (est)  $11.99 Ref,2017-05-22 13:11:00-04:00,ENDP,positive
422390.0,20 Biggest Mid-Day Gainers For Tuesday,2017-05-09 12:17:00-04:00,ENDP,neutral
422391.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-05-09 08:16:00-04:00,ENDP,neutral
422392.0,"Endo Int'l Reaffirms FY1 Sales, Adj. EBITDA, Adj. EPS Outlook",2017-05-09 06:39:00-04:00,ENDP,neutral
422393.0,"Endo Int'l Reports Q1 Adj. EPS $1.23 vs $1.30 Est., Sales $1.038B",2017-05-09 06:38:00-04:00,ENDP,neutral
422394.0,"Earnings Scheduled For May 9, 2017",2017-05-09 04:32:00-04:00,ENDP,neutral
422395.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-05-04 08:06:00-04:00,ENDP,neutral
422396.0,"Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?",2017-04-30 12:38:00-04:00,ENDP,positive
422397.0,22 Stocks Moving In Friday's Pre-Market Session,2017-04-28 08:20:00-04:00,ENDP,neutral
422398.0,22 Stocks Moving In Thursday's Pre-Market Session,2017-04-27 08:32:00-04:00,ENDP,neutral
422399.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-04-26 08:22:00-04:00,ENDP,neutral
422400.0,25 Stocks Moving In Friday's Pre-Market Session,2017-04-21 08:31:00-04:00,ENDP,neutral
422401.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-04-20 08:12:00-04:00,ENDP,neutral
422402.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-04-19 08:53:00-04:00,ENDP,neutral
422403.0,Watch These 8 Huge Call Purchases In Monday Trade,2017-04-17 04:32:00-04:00,ENDP,positive
422404.0,Benzinga's Option Alert Recap From April 13,2017-04-13 16:49:00-04:00,ENDP,positive
422405.0,Option Alert: Endo Apr 11.5 Calls Sweep: 1556 @  ASK  $0.15: 1673 traded vs 2602 OI:  Earnings 5/4 Before Open [est]  $10.55 Ref,2017-04-13 13:28:00-04:00,ENDP,positive
422406.0,"Endo Int'l Reports Proposed Offering of Senior Secured Notes, No Amount Disclosed",2017-04-10 13:28:00-04:00,ENDP,positive
422407.0,"8-K from Endo Int'l Shows Expectation for Q1 Sales $1.015B-$1.035B vs $1.02B Est., Adj. EBITDA $440M-$460M",2017-04-10 08:09:00-04:00,ENDP,neutral
422408.0,Hearing Fresenius Said to Consider Offer for Akorn,2017-04-07 13:06:00-04:00,ENDP,neutral
422409.0,"Endo Int'l Shares Spike Into Positive Territory, Now Up 2%, Vertex Shares Also at Session Highs Up 2.3%",2017-04-07 13:05:00-04:00,ENDP,positive
422410.0,Endo International plc REports Plan to Refinance Existing Credit Facilities,2017-04-05 07:30:00-04:00,ENDP,positive
422411.0,"If Gender Confirmation Becomes A Legal Human Right, Which Corporations Could Benefit?",2017-03-28 13:05:00-04:00,ENDP,positive
422412.0,Leerink Presents: Your 2017 Biopharma Catalyst Tracker,2017-03-20 09:17:00-04:00,ENDP,neutral
422413.0,Egalet Says FDA Saw Unintended Consequence Of IV Abuse Potential With Endo's Opana ER,2017-03-16 09:07:00-04:00,ENDP,negative
422414.0,"UPDATE: Egalet, On Market Potential Of Its ARMYO ER In Light Of FDA Vote On Endo's Opana ER, Highlights to Benzinga ARYMO ER Has IV-Abuse Deterrent Claim, Gelling Properties Resist Passage Through Syringe",2017-03-16 08:56:00-04:00,ENDP,neutral
422415.0,"Egalet, Responding To FDA Panel Vote On Endo's Opana ER, Tells Benzinga Panel Saw Unintended Consequence Of IV Abuse Potential With Opana ER",2017-03-16 08:56:00-04:00,ENDP,negative
422416.0,Watch These 8 Huge Put Purchases In Thursday Trade,2017-03-16 04:01:00-04:00,ENDP,positive
422417.0,Endo Mar $10 Put 4500 @Bid @$0.15; REf=$10.05,2017-03-15 12:22:00-04:00,ENDP,neutral
422418.0,How Endo's FDA Committee Vote Affects Egalet,2017-03-15 10:38:00-04:00,ENDP,neutral
422419.0,Endo Responds to FDA Advisory Committee Vote Related to OPANA ER; Says Confident Painkiller has Favorable Risk-benefit Profile When Used as Intended,2017-03-15 03:58:00-04:00,ENDP,positive
422420.0,Benzinga's Option Alert Recap From March 14,2017-03-14 17:00:00-04:00,ENDP,positive
422421.0,Option Alert: ENDP Mar 10.0 Puts Sweep: 578 @  ASK  $0.25: 1143 traded vs 674 OI:  Earnings 5/4 Before Open (est)  $10.21 Ref,2017-03-14 15:34:00-04:00,ENDP,positive
422422.0,Endo Shares Turn Negative Over Last Min as Hearing an FDA Panel Has Voted 18-8 Reformulated Opana ER Do Not Continue to Outweigh Risks,2017-03-14 15:33:00-04:00,ENDP,negative
422423.0,REMINDER: FDA Expected To Conclude Advisory Committe Meeting Related To Endo International's Reformulated Opana ER Today,2017-03-14 14:25:00-04:00,ENDP,neutral
422424.0,Endo International To Delist Ordinary Shares From Toronto Stock Exchange As Of March 17,2017-03-03 16:35:00-05:00,ENDP,positive
422425.0,Endo Sees FY 2017 Sales $3.45B to $3.60B vs $3.82B Est,2017-02-28 06:36:00-05:00,ENDP,neutral
422426.0,"Endo Q4 EPS $1.77 vs $1.63 Est, Sales $1.24B vs $1.16B Est",2017-02-28 06:35:00-05:00,ENDP,neutral
422427.0,"Earnings Scheduled For February 28, 2017",2017-02-28 04:54:00-05:00,ENDP,neutral
422428.0,UPDATE: Regency Centers Will Replace Endo Int'l in S&P 500,2017-02-23 17:20:00-05:00,ENDP,neutral
422429.0,Canaccord Genuity Initiates Coverage On Endo International plc - Ordinary Shares to Hold,2017-02-22 06:41:00-05:00,ENDP,positive
422430.0,"Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP",2017-01-30 17:27:00-05:00,ENDP,positive
422431.0,"Endo Announces Restructuring Program, Expects to Cut 90 Jobs, Sees $40M to $50M of Cost Savings",2017-01-26 06:35:00-05:00,ENDP,negative
422432.0,"FTC Keeps Pressure On Wall Street, Refiles Suit Against Allergan, Others",2017-01-23 15:18:00-05:00,ENDP,negative
422433.0,"UPDATE: Endo International Admits To No Wrongdoing, No Monetary Payment Made By Endo",2017-01-23 14:19:00-05:00,ENDP,negative
422434.0,Endo Press Release Confirms Agreement To Resolve FTC Investigation And Litigation,2017-01-23 14:18:00-05:00,ENDP,positive
422435.0,"FTC Refiles Suits Against Allergan For Blocking Lower-Cost Generic Version Of Painkiller Lidoderm, FTC Issues Administrative Complaint Against Impax Lab For Similar Scheme With Regard To Opana ER",2017-01-23 14:07:00-05:00,ENDP,negative
422436.0,"Hearing an FTC Antitrust Suit Challenges Alleged Reverse-Payment Deal Between Endo, Watson Labs as Obstruction to Generic Rivals of Endo's Lidoderm",2017-01-23 13:43:00-05:00,ENDP,positive
422437.0,Shares Of Allergan & Endo International Move Lower; Hearing FTC Has Sued Both Companies In Federal Court,2017-01-23 13:30:00-05:00,ENDP,neutral
422438.0,The Market In 5 Minutes: Trump Inauguration Takes Center Stage,2017-01-20 09:02:00-05:00,ENDP,neutral
422439.0,JP Morgan Downgrades Endo International plc - Ordinary Shares to Neutral,2017-01-20 06:03:00-05:00,ENDP,positive
422440.0,Nearly 200 S&P 500 Stocks Are Now In Correction Territory,2017-01-10 14:50:00-05:00,ENDP,neutral
422441.0,The Fentanyl Abuse Epidemic,2017-01-10 07:02:00-05:00,ENDP,negative
422442.0,"UPDATE: Endo Int'l Sees FY16 Adj. EPS $4.50-$4.80 vs $4.59 Est., Sales $3.87B-$4.03B vs $3.93B Est.",2017-01-09 11:03:00-05:00,ENDP,neutral
422443.0,"8-K from Endo Int'l Shows Reaffirmed FY16 Sales, Adj. EPS Outlook",2017-01-09 11:02:00-05:00,ENDP,neutral
422444.0,"Benzinga's Top Upgrades, Downgrades For January 5, 2017",2017-01-05 09:24:00-05:00,ENDP,positive
422445.0,"Citigroup Downgrades Endo International plc - Ordinary Shares to Neutral, Lowers Target to $20.00",2017-01-05 05:50:00-05:00,ENDP,positive
422446.0,The Year-End Tax-Selling Strategy,2017-01-02 10:42:00-05:00,ENDP,neutral
422447.0,Which Wall Street Firm Made The Best Stock Picks Of 2016?,2016-12-30 10:09:00-05:00,ENDP,positive
422448.0,2016's Window-Dressing Stocks: Portfolio Managers Likely To Add And Eliminate These Issues,2016-12-29 14:52:00-05:00,ENDP,neutral
422449.0,Should You Be Buying 2016 Market Leaders Or Laggards Heading Into 2017?,2016-12-28 13:55:00-05:00,ENDP,neutral
422450.0,6 Worst Performing S&P 500 Stocks Of 2016,2016-12-27 10:41:00-05:00,ENDP,negative
422451.0,Endo Names Blaise Coleman CFO,2016-12-20 07:34:00-05:00,ENDP,neutral
422452.0,CNBC's List Of 20 Beaten-Up Stocks,2016-12-15 12:36:00-05:00,ENDP,neutral
422453.0,First Charges Filed in Generic Drug Price Probe: Connected Stocks Sell Off,2016-12-14 13:32:00-05:00,ENDP,negative
422454.0,"Weakness in Several Pharma Names Being Attributed to Bloomberg Report Lannett, Impax, Endo, Taro, Actavis, Covis, Sun Pharma, Mayne Received Subpoenas",2016-12-14 12:15:00-05:00,ENDP,negative
422455.0,Endo Begins Shipment of Generic ZETIA,2016-12-12 07:30:00-05:00,ENDP,neutral
422456.0,"Belbuca Revenue 'Immaterial,' Says JMP On Rx's Return To BioDelivery From Endo International",2016-12-09 10:36:00-05:00,ENDP,neutral
422457.0,Endo to Eliminate 375 Member Pain Salesforce Following Sale of Belbuca to BDSI,2016-12-08 06:17:00-05:00,ENDP,negative
422458.0,"Endo Int'l Shares Down 5.61% On Above Average Volume; Hearing Oppenheimer Resumed Coverage At Perform, Cautious On The Name Citing Challenging Environment",2016-12-07 12:24:00-05:00,ENDP,positive
422459.0,Endo Begins Shipment of Generic CellCept,2016-12-06 07:35:00-05:00,ENDP,neutral
422460.0,"Endo Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite, Highly Statistically Significant Results (P<0.001) Demonstrated on Primary Composite Endpoint and All Secondary Endpoints",2016-11-17 08:31:00-05:00,ENDP,positive
422461.0,Susquehanna Upgrades Endo International plc - Ordinary Shares to Positive,2016-11-10 08:56:00-05:00,ENDP,positive
422462.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,ENDP,neutral
422463.0,From Endo Int'l Q3 Earnings Conference Call: CEO Sees Pricing Pressure on US Generic Products Likely Steeper Heading In To '17,2016-11-08 09:01:00-05:00,ENDP,negative
422464.0,22 Stocks Moving In Tuesday's Pre-Market Session,2016-11-08 08:34:00-05:00,ENDP,neutral
422465.0,"Endo Sees FY 2016 EPS $4.50 to $4.80 vs $4.55 Est, Revenue $3.87B to $4.03B vs $3.93B Est",2016-11-08 06:32:00-05:00,ENDP,neutral
422466.0,"Endo Q3 EPS $1.01 vs $0.81 Est, Revenue $884.3M vs $862.3M Est",2016-11-08 06:32:00-05:00,ENDP,neutral
422467.0,"Earnings Scheduled For November 8, 2016",2016-11-08 04:27:00-05:00,ENDP,neutral
422468.0,"Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks",2016-11-04 13:53:00-04:00,ENDP,negative
422469.0,Hearing Endo Int'l Held Talks to Sell Paladin Labs to Knight Therapeutics,2016-11-04 10:40:00-04:00,ENDP,neutral
422470.0,"Hearing Dept. of Justice is Probing Generic Cos., Mylan, Teva, Actavis, Impax, Endo's Par, Covis, Lannett, Others Received Subpoenas",2016-11-03 14:14:00-04:00,ENDP,positive
422471.0,Aurinia Pharma Merits Speculative Buy On M&A Appeal; Phase 3 Study Remains Paramount,2016-11-02 12:05:00-04:00,ENDP,positive
422472.0,"Watch Shares Of Horizon Pharma, Mallinckrodt, Endo International, Depomed, In Sympathy To Dow Jones Report of Valeant Selling Salix Unit",2016-11-01 15:54:00-04:00,ENDP,positive
422473.0,Endo Begins Shipment of Generic SEROQUEL XR,2016-11-01 07:36:00-04:00,ENDP,neutral
422474.0,10 Stocks Which Rallied Three Days On Increasing Volume,2016-10-24 07:02:00-04:00,ENDP,neutral
422475.0,Watch These 7 Huge Call Purchases In Friday Trade,2016-10-21 00:52:00-04:00,ENDP,positive
422476.0,"Endo CFO Suketu Upadhyay To Leave Company, Names Blaise Coleman Interim CFO",2016-10-20 16:09:00-04:00,ENDP,negative
422477.0,Option Alert: ENDP Fri 10/28 21.5 Calls (Wkly) Sweep: 598 @  ASK  $0.35: 872 traded vs 23 OI:  Earnings 11/8 Before Market (conf)  $20.46 Ref,2016-10-20 14:59:00-04:00,ENDP,positive
422478.0,Endo International Now Offers Double-Digits Upside: Vetr,2016-10-18 14:23:00-04:00,ENDP,neutral
422479.0,Endo Int'l Shares Up 4%; Guggenheim Earlier Suggested Shares Valued in $30-$51 Range Given Sum-of-the-Parts Analysis,2016-10-14 10:59:00-04:00,ENDP,positive
422480.0,Analysts Share Their Low Forward P/E Picks,2016-10-12 06:52:00-04:00,ENDP,neutral
422481.0,Endo Pharma Issues New Phase 2 Data for XIAFLEX: Study Participants in the Higher Dose Groups Treated with a Single Injection of XIAFLEX® Showed Statistically Significant Decrease in Size and Hardness,2016-09-30 07:30:00-04:00,ENDP,positive
422482.0,Northland Securities Upgrades Endo International to Outperform,2016-09-29 09:34:00-04:00,ENDP,positive
422483.0,Watch These 5 Huge Put Purchases In Monday Trade,2016-09-26 02:50:00-04:00,ENDP,positive
422484.0,"Option Alert: ENDP Sept. 30 $23.5 Puts at the bid: Volume of 19,000 @ 0.551 vs 2 Open Interest",2016-09-23 12:55:00-04:00,ENDP,positive
422485.0,18 Biggest Mid-Day Gainers For Friday,2016-09-23 12:39:00-04:00,ENDP,neutral
422486.0,"Endo Affirms Q3 Rev. $830-$870M vs. Est. $864M, EPS $0.77-$0.82 vs. Est. $0.82; FY16 Rev. $3.87B-$4.03B vs. Est. $3.93B, EPS $4.50-$4.80 vs. Est. $4.56",2016-09-23 07:06:00-04:00,ENDP,neutral
422487.0,Endo Names Paul Campanelli President and CEO,2016-09-23 07:02:00-04:00,ENDP,neutral
422488.0,The Market In 5 Minutes: Hillary Clinton Falls Ill With The Global Stock Markets,2016-09-12 08:55:00-04:00,ENDP,negative
422489.0,Can You Guess This Chart?,2016-09-12 07:23:00-04:00,ENDP,neutral
422490.0,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 17:09:00-04:00,ENDP,negative
422491.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 10:26:00-04:00,ENDP,neutral
422492.0,"Option Alert: Endo Sep $19.5 Put; 4,000 @Bid @$0.51; Ref = $20.22",2016-09-02 10:38:00-04:00,ENDP,positive
422493.0,Endo Shares Ticking Higher; Traders Circulating Unconfirmed Takeover Chatter,2016-09-02 10:28:00-04:00,ENDP,positive
422494.0,"Top Performing Industries For August 24, 2016",2016-08-24 10:50:00-04:00,ENDP,positive
422495.0,Benzinga's Top Upgrades,2016-08-12 09:01:00-04:00,ENDP,positive
422496.0,18 Stocks Moving In Friday's Pre-Market Session,2016-08-12 08:19:00-04:00,ENDP,neutral
422497.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of J C Penney Earnings,2016-08-12 07:26:00-04:00,ENDP,neutral
422498.0,"Endo Withdraws Its SNDA For OPANA, Shares Rise",2016-08-12 07:18:00-04:00,ENDP,positive
422499.0,Endo To Withdraw its sNDA Relating To Specific Abuse Labeling For OPANA ER Without Prejudice To Re-Filing; Financial Projections For 2016 Did Not Assume This Approval,2016-08-12 07:06:00-04:00,ENDP,negative
422500.0,Mizuho Securities Upgrades Endo International to Buy,2016-08-12 06:31:00-04:00,ENDP,positive
422501.0,Tuesday's Market Wrap: Stocks Little Changed Once Again,2016-08-09 17:37:00-04:00,ENDP,neutral
422502.0,Mid-Afternoon Market Update: Endo Rises On Earnings Beat; Impax Laboratories Shares Slide,2016-08-09 14:33:00-04:00,ENDP,positive
422503.0,18 Biggest Mid-Day Gainers For Tuesday,2016-08-09 12:44:00-04:00,ENDP,neutral
422504.0,"Top Performing Industries For August 9, 2016",2016-08-09 10:54:00-04:00,ENDP,positive
422505.0,22 Stocks Moving In Tuesday's Pre-Market Session,2016-08-09 08:48:00-04:00,ENDP,neutral
422506.0,Watch These 7 Huge Put Purchases In Tuesday Trade,2016-08-09 02:42:00-04:00,ENDP,positive
422507.0,"After-Hours Gainers Aug. 8, 2016: HIIQ Up 36%, REN 20%, CCXI 14.4%, FH 14.3%, FGEN 10.4%, AMPH 9.4%, CSLT 8.9%, NVRO 8.7%, ENDP 7.5%",2016-08-08 18:58:00-04:00,ENDP,neutral
422508.0,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients,2016-08-08 16:59:00-04:00,ENDP,negative
422509.0,"Endo Reaffirms FY16 Outlook: Sales $3.87B-$4.03B vs $3.93B Est., Adj. EPS $4.50-$4.80 vs $4.54 Est.",2016-08-08 16:34:00-04:00,ENDP,neutral
422510.0,"Endo Int'l Reports Q2 Adj. EPS $0.86 vs $0.74 Est., Sales $921M vs $864.3M Est.",2016-08-08 16:33:00-04:00,ENDP,neutral
422511.0,"Endo Reports Q2 Adj EPS $0.86 vs $0.74 Est, Rev $921M vs $864.34M Est",2016-08-08 16:30:00-04:00,ENDP,neutral
422512.0,Option Alert: ENDP Oct16 10.0 Puts Sweep: 637 @  ASK  $0.20: 637 traded vs 3094 OI:  Earnings today After Close  $18.08 Ref,2016-08-08 15:41:00-04:00,ENDP,positive
422513.0,10 Stocks You Should Be Watching Today,2016-08-08 04:52:00-04:00,ENDP,neutral
422514.0,"Earnings Scheduled For August 8, 2016",2016-08-08 04:12:00-04:00,ENDP,neutral
422515.0,Endo Spikes to High of $17.74 on Volume; Traders Attributing to Takeover Chatter; Perrigo Mentioned as Potential Buyer,2016-08-03 11:29:00-04:00,ENDP,neutral
422516.0,"Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science",2016-07-21 08:40:00-04:00,ENDP,positive
422517.0,5 Stocks Cut In Half In 2016,2016-07-05 11:26:00-04:00,ENDP,negative
422518.0,Option Alert: ENDP Aug16 20.0 Calls Sweep: 912 @  ASK  $1.00: 912 traded vs 150 OI:  Earnings 8/8  $16.52 Ref,2016-07-01 10:26:00-04:00,ENDP,positive
422519.0,BMO Capital Initiates Coverage on Endo International at Market Perform,2016-06-29 06:26:00-04:00,ENDP,neutral
422520.0,Watch These 4 Huge Put Purchases In Wednesday Trade,2016-06-29 04:26:00-04:00,ENDP,positive
422521.0,Option Alert: ENDP Jul16 16.0 Puts: 742 @  ASK  $0.90: 909 traded vs 78 OI:  Earnings 8/8  $16.35 Ref,2016-06-28 15:46:00-04:00,ENDP,positive
422522.0,Endo International Sharply Higher,2016-06-28 13:12:00-04:00,ENDP,neutral
422523.0,Endo Resumes Trade; Spikes to High of $16.41,2016-06-28 12:46:00-04:00,ENDP,neutral
422524.0,Endo Shares Spike to High of $15.18; Halted on CB,2016-06-28 12:41:00-04:00,ENDP,positive
422525.0,Endo Announces Issuance of Vasostrict Patent,2016-06-28 12:37:00-04:00,ENDP,neutral
422526.0,Endo Exploring Asset Sales -Reuters,2016-06-27 17:23:00-04:00,ENDP,positive
422527.0,Watch Out For Extreme Volatility In Lipocine On Tuesday,2016-06-27 16:28:00-04:00,ENDP,neutral
422528.0,Option Alert: ENDP Aug16 17.5 Calls Sweep: 756 @  ASK  $1.35: 877 traded vs 191 OI:  Earnings 8/8  $15.73 Ref,2016-06-23 14:55:00-04:00,ENDP,positive
422529.0,"Endo Pharma Reports FDA Panel Meeting for OPANA ER Will Be Jul. 29, '16",2016-06-15 08:31:00-04:00,ENDP,neutral
422530.0,Benzinga's Top Upgrades,2016-06-13 09:07:00-04:00,ENDP,positive
422531.0,Mizuho Securities Upgrades Endo International to Neutral,2016-06-13 06:41:00-04:00,ENDP,positive
422532.0,"Monosol RX Wins Patent Infringement Suit vs Par Pharmaceutical, Watson Pharmaceuticals Related To Suboxone Sublingual Film",2016-06-07 11:09:00-04:00,ENDP,positive
422533.0,"Goldman Initiates Specialty Pharma At Neutral, Highlights 'A Confluence Of Concerns'",2016-06-06 13:22:00-04:00,ENDP,neutral
422534.0,"Goldman Initiates Impax Labs With Sell Rating, $33 Target",2016-06-06 11:46:00-04:00,ENDP,neutral
422535.0,"Goldman Sachs Initiates Coverage on Endo International at Neutral, Announces $20.00 PT",2016-06-06 07:23:00-04:00,ENDP,neutral
422536.0,"Endo Pharmaceuticals Reports Safety, Tolerability Of BELBUCA At ICOO In Boston For June 5-7th",2016-06-03 08:02:00-04:00,ENDP,positive
422537.0,"FBR Midday Desk Comments Note Biotech Flows Are Beginning To Wane Following ASCO Over Weekend, Says Data Being Met With Aggressive Short Covering",2016-06-01 12:43:00-04:00,ENDP,negative
422538.0,"Top Performing Industries For June 1, 2016",2016-06-01 10:56:00-04:00,ENDP,positive
422539.0,Option Alert: ENDP Jul16 20.0 Calls Sweep: 707 @  ASK  $0.50: 790 traded vs 449 OI: $15.89 Ref,2016-05-31 11:22:00-04:00,ENDP,positive
422540.0,"Susquehanna Says VRX Bid From TPG/TAKEDA May Put A Floor Under ENDP, LCI, AKRX",2016-05-31 08:58:00-04:00,ENDP,neutral
422541.0,13F From George Soros Shows Liquidated Stake In Endo International,2016-05-16 16:44:00-04:00,ENDP,neutral
422542.0,Option Alert: ENDP May16 14.0 Calls Sweep: 2015 @  ASK  $1.00: 2150 traded vs 8985 OI: $13.76 Ref,2016-05-13 10:18:00-04:00,ENDP,positive
422543.0,Option Alert: ENDP May16 15.0 Calls Sweep: 2500 @  ASK  $0.50: 2501 traded vs 1090 OI: $13.69 Ref,2016-05-12 09:32:00-04:00,ENDP,positive
422544.0,Option Alert: ENDP May16 14.0 Calls: 5000 @  ASK  $0.80: 5113 traded vs 8 OI: $13.53 Ref,2016-05-11 15:59:00-04:00,ENDP,positive
422545.0,"Chairman Kimmel Buys 7,000 Shares of Endo International @$15.53/Share -Form 4",2016-05-11 14:29:00-04:00,ENDP,positive
422546.0,"Paul Campanelli Buys 13,000 Shares of Endo International @$15.53/Share -Form 4",2016-05-11 14:22:00-04:00,ENDP,positive
422547.0,"Cantor Doesn't Think BioDelivery Sciences Should Be Cutting To Grow, Downgrades Stock To Hold",2016-05-11 09:52:00-04:00,ENDP,negative
422548.0,"After-Hours Recap: Indexes Up Friday, But Still Down For The Week",2016-05-07 14:34:00-04:00,ENDP,neutral
422549.0,Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Endo International Shares Plunge,2016-05-06 14:30:00-04:00,ENDP,positive
422550.0,Mid-Day Market Update: Yelp Surges On Upbeat Results; Square Shares Decline,2016-05-06 12:18:00-04:00,ENDP,positive
422551.0,"Worst Performing Industries For May 6, 2016",2016-05-06 11:58:00-04:00,ENDP,negative
422552.0,Stocks Hitting 52-Week Lows,2016-05-06 10:17:00-04:00,ENDP,negative
422553.0,Mid-Morning Market Update: Markets Edge Lower; Cognizant Issues Weak Q2 Outlook,2016-05-06 09:52:00-04:00,ENDP,negative
422554.0,15 Stocks Moving In Friday's Pre-Market Session,2016-05-06 08:22:00-04:00,ENDP,neutral
422555.0,Piper Jaffray Downgrades Endo International to Neutral,2016-05-06 07:22:00-04:00,ENDP,neutral
422556.0,Mizuho Securities Downgrades Endo International to Underperform,2016-05-06 07:19:00-04:00,ENDP,positive
422557.0,RBC Capital Downgrades Endo International to Sector Perform,2016-05-06 06:52:00-04:00,ENDP,neutral
422558.0,"Endo Reports Q1 EPS $1.08 vs. Est. $1.04, Rev. $964m vs. Est. $955M",2016-05-05 17:34:00-04:00,ENDP,neutral
422559.0,"Earnings Scheduled For May 5, 2016",2016-05-05 04:36:00-04:00,ENDP,neutral
422560.0,Endo Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property,2016-05-02 08:01:00-04:00,ENDP,positive
422561.0,"After-Hours Recap: Index Movers, Earnings And Charter-Time Warner Cable Deal",2016-04-25 17:15:00-04:00,ENDP,neutral
422562.0,Option Alert: ENDP Jun16 35.0 Calls Sweep: 1390 @  ASK  $4.40: 5953 traded vs 261 OI:  Earnings 5/9  $33.28 Ref,2016-04-22 13:07:00-04:00,ENDP,positive
422563.0,Option Alert: ENDP May16 31.5 Calls Sweep: 1354 @  ASK  $3.61: 25k traded vs 0 OI:  Earnings 5/9  $31.16 Ref,2016-04-21 15:14:00-04:00,ENDP,positive
422564.0,JMP Securities Initiates Coverage on Endo International at Outperform,2016-04-21 09:30:00-04:00,ENDP,positive
422565.0,Option Alert: ENDP May16 28.0 Puts: 2050 @  ASK  $3.30: 2050 traded vs 0 OI:  Earnings 5/9  $28.48 Ref,2016-04-20 13:16:00-04:00,ENDP,positive
422566.0,"After-Hours Recap: IBM & Netflix's Earnings, Index Movers And Apple's Decline",2016-04-18 17:23:00-04:00,ENDP,neutral
422567.0,Option Alert: ENDP May16 27.5 Calls Sweep: 1010 @  ASK  $3.50: 1362 traded vs 22k OI:  Earnings 5/9  $27.55 Ref,2016-04-18 10:42:00-04:00,ENDP,positive
422568.0,Jazz Pharma Investors: Did You Catch This Favorable Ruling?,2016-04-13 11:51:00-04:00,ENDP,positive
422569.0,"Benzinga's M&A Chatter for Monday April 11, 2016",2016-04-11 20:38:00-04:00,ENDP,neutral
422570.0,"Monday's After-Hours Recap: Index Movers, Alcoa's Earnings & More",2016-04-11 17:22:00-04:00,ENDP,neutral
422571.0,Option Alert: ENDP Jul16 35.0 Calls Sweep: 542 @  ASK  $1.60: 756 traded vs 1980 OI:  Earnings 5/9  $26.43 Ref,2016-04-11 12:18:00-04:00,ENDP,positive
422572.0,Option Alert: ENDP May16 35.0 Calls Sweep: 1606 @  ASK  $0.80: 1620 traded vs 1542 OI:  Earnings 5/9  $26.12 Ref,2016-04-11 12:10:00-04:00,ENDP,positive
422573.0,"CORRECTION: ENDP Shares Spike, DealReporter Says AGN Could Be Looking To Buy ENDP",2016-04-11 12:04:00-04:00,ENDP,positive
422574.0,"ENDP Shares Spike, DealReporter Says AGN Could Be Looking To Buy ENDP",2016-04-11 12:03:00-04:00,ENDP,positive
422575.0,"Worst Performing Industries For April 11, 2016",2016-04-11 11:16:00-04:00,ENDP,negative
422576.0,Option Alert: ENDP Fri 4/22 28.0 Calls (Wkly) Sweep: 500 @  ASK  $1.00: 500 traded vs 0 OI:  Earnings 5/9  $26.76 Ref,2016-04-11 10:22:00-04:00,ENDP,positive
422577.0,Option Alert: ENDP Apr16 35.0 Calls: 11802 @  ASK  $0.15: 12k traded vs 2987 OI:  Earnings 5/9  $29.55 Ref,2016-04-07 12:55:00-04:00,ENDP,positive
422578.0,"After-Hours Recap: Bed Bath & Beyond, Apollo, Valeant, eBay & More",2016-04-06 18:36:00-04:00,ENDP,neutral
422579.0,Option Alert: ENDP Apr16 28.0 Calls Sweep: 1346 @  ASK  $1.70: 1347 traded vs 20 OI:  Earnings 5/9  $28.16 Ref,2016-04-06 11:40:00-04:00,ENDP,positive
422580.0,"Worst Performing Industries For April 5, 2016",2016-04-05 11:17:00-04:00,ENDP,negative
422581.0,Worst Stocks Of The First Quarter,2016-03-31 13:27:00-04:00,ENDP,negative
422582.0,Endo Says FTC Case Without Merit,2016-03-31 11:10:00-04:00,ENDP,negative
422583.0,Stocks Hitting 52-Week Lows,2016-03-31 10:23:00-04:00,ENDP,negative
422584.0,UPDATE: FTC Complaint Also Names Allergan,2016-03-31 09:35:00-04:00,ENDP,negative
422585.0,FTC Sues Endo Pharmaceuticals Inc. and Others for Illegally Blocking Lower-Cost Generic Versions of the Branded Drugs Opana ER and Lidoderm,2016-03-31 09:34:00-04:00,ENDP,negative
422586.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-28 17:38:00-04:00,ENDP,neutral
422587.0,"Endo's Selloff An 'Overreaction,' Nomura Says",2016-03-21 10:44:00-04:00,ENDP,neutral
422588.0,RBC Capital Downgrades Endo International to Outperform,2016-03-18 05:36:00-04:00,ENDP,neutral
422589.0,Option Alert: ENDP Jul16 35.0 Calls: 1200 @  ASK  $3.20: 1257 traded vs 116 OI:  Earnings 5/9  $28.10 Ref,2016-03-17 12:23:00-04:00,ENDP,positive
422590.0,Stocks Hitting 52-Week Lows,2016-03-17 10:12:00-04:00,ENDP,negative
422592.0,"William Spengler Buys 1,000 Shares of Endo @$35.24/Share -Form 4",2016-03-16 13:38:00-04:00,ENDP,positive
422593.0,Option Alert: ENDP Jul16 30.0 Puts Sweep: 553 @  ASK  $5.10: 770 traded vs 10 OI:  Earnings 5/9  $32.57 Ref,2016-03-15 15:59:00-04:00,ENDP,positive
422594.0,Endo Shares Sell Off to Low; April 35 Call Being Sold,2016-03-15 15:05:00-04:00,ENDP,neutral
422595.0,"Chairman Kimmel Buys 1,125 Shares of Endo International @$41.94/Share -Form 4",2016-03-14 15:12:00-04:00,ENDP,positive
422596.0,"CEO de Silva Buys 2,250 of Endo International @$44.50/Share -Form 4",2016-03-07 16:00:00-05:00,ENDP,neutral
422597.0,"Nomura Maintains Buy on Endo International, Lowers PT to $80.00",2016-03-04 06:10:00-05:00,ENDP,negative
422598.0,"Barclays Maintains Equal-weight on Endo International, Lowers PT to $55.00",2016-03-04 03:44:00-05:00,ENDP,negative
422599.0,Worst Stock Ideas Of February,2016-03-01 12:37:00-05:00,ENDP,negative
422600.0,"Stifel Nicolaus Maintains Buy on Endo International, Lowers PT to $110.00",2016-03-01 08:13:00-05:00,ENDP,negative
422601.0,"Earnings Recap For February 29: Lumber Liquidators, Taser & More",2016-02-29 16:38:00-05:00,ENDP,neutral
422602.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-02-29 16:36:00-05:00,ENDP,neutral
422603.0,Endo International Tanks After Revealing It Will Close Astora Women's Health Division,2016-02-29 14:01:00-05:00,ENDP,neutral
422604.0,"UPDATE: Nomura Understands Investors Being Risk Adverse In ENDP, Sees Potential For Belbuca To Drive Organic Growth",2016-02-29 11:54:00-05:00,ENDP,negative
422605.0,"Nomura Defends Endo Int'l, Says Weakness Is Buying Opportunity",2016-02-29 11:52:00-05:00,ENDP,neutral
422606.0,"Endo Intl Q4 EPS $1.36 vs $1.27 est, Revenue $1.07B vs $1.07B est",2016-02-29 06:36:00-05:00,ENDP,neutral
422607.0,"Keep an Eye on These 7 Stocks for February 29, 2016",2016-02-29 04:46:00-05:00,ENDP,neutral
422608.0,"Earnings Scheduled For February 29, 2016",2016-02-29 04:04:00-05:00,ENDP,neutral
422609.0,Endo Reports Launch Of BELBUCA Buccal Film For Chronic Pain Management,2016-02-22 07:31:00-05:00,ENDP,negative
422610.0,Endo Begins Phase 2B Clinical Trial Of Collagenase Clostridium Histolyticum In Cellulite,2016-02-17 09:03:00-05:00,ENDP,neutral
422611.0,Endo Reports Initiation of Phase 2B Trial of Collagenase Clostridium Histolyticum in Cellulite,2016-02-17 09:01:00-05:00,ENDP,neutral
422612.0,13F from Lone Pine Capital Shows Liquidated Position in Endo Int'l,2016-02-16 17:29:00-05:00,ENDP,negative
422613.0,Option Alert: ENDP Feb16 51.5 Calls Sweep: 500 @  ASK  $1.30: 503 traded vs 10 OI:  Earnings 3/7  $48.43 Ref,2016-02-11 15:14:00-05:00,ENDP,positive
422614.0,Hearing Unconfirmed Market Chatter Endo Cancelled Out of Leerink Conference Next Week,2016-02-05 13:34:00-05:00,ENDP,negative
422615.0,Endo Spikes to High of $56.71 on Volume,2016-02-05 13:34:00-05:00,ENDP,neutral
422616.0,Perrigo Declines Comment on Rumored Bid for Endo,2016-01-26 14:00:00-05:00,ENDP,neutral
422617.0,Hearing Unconfirmed Market Chatter of Perrigo $79/Share Bid for Endo,2016-01-26 12:05:00-05:00,ENDP,negative
422618.0,"Barclays Initiates Coverage on Endo International at Equal-weight, Announces $70.00 PT",2016-01-21 05:23:00-05:00,ENDP,neutral
422619.0,Endo International Notifies Vivus It Will End Its Commercial Supply And License Agreements Related To Avanafil,2015-12-31 08:32:00-05:00,ENDP,positive
422620.0,"Acerus Reports Termination Of NATESTO Agreement With Endo, Company To Sell And Distribute In U.S. Until Effective Date Of Termination",2015-12-31 07:04:00-05:00,ENDP,positive
422621.0,"8-K from Endo Int'l Shows Unit Auxilium Pharma, Endo Ventures, Provided Written Notice to VIVUS Related to Termination of License, Commercialization Deal",2015-12-30 16:39:00-05:00,ENDP,neutral
422622.0,Hearing Endo Int'l's Qualitest Pharma Will Pay $39M to Resolve Claims Related to Fluoride Labeling,2015-12-16 16:26:00-05:00,ENDP,positive
422623.0,"Endo Announces Extension Of U.S. Rights For Voltaren Gel Through June 30, 2023",2015-12-14 08:10:00-05:00,ENDP,neutral
422624.0,Endo Int'l Reports Extension of US Rights for Voltaren Gel,2015-12-14 08:02:00-05:00,ENDP,neutral
422625.0,"Depomed Acquires U.S. Rights to Late-Stage, First-in-Class Pain Product from Grunentha",2015-11-17 16:26:00-05:00,ENDP,negative
422626.0,"Watch Out Below, Endo International Investors, Management Is Doubling Down On Weak Assets",2015-11-16 13:38:00-05:00,ENDP,negative
422627.0,Benzinga's Top Downgrades,2015-11-16 09:26:00-05:00,ENDP,positive
422628.0,Mizuho Securities Downgrades Endo International to Neutral,2015-11-16 06:36:00-05:00,ENDP,positive
422629.0,"Ronnie Moas Downgrades Kite Pharma, Sees $100 Stock Price Through 2018",2015-11-14 14:49:00-05:00,ENDP,neutral
422630.0,Standpoint Research Upgrades Endo International to Buy,2015-11-13 10:11:00-05:00,ENDP,neutral
422631.0,Endo Shares Spike to High,2015-11-13 10:02:00-05:00,ENDP,positive
422632.0,"Mallinckrodt The Latest To Feel Citron's Wrath, Has Significantly More Downside Than Valeant",2015-11-09 15:22:00-05:00,ENDP,negative
422633.0,Endo Shares Volatile After Citron Tweet On Malinckrodt,2015-11-09 13:55:00-05:00,ENDP,positive
422634.0,Endo Reports It Will Enter Program To Repurchase $250M Stock Under Previously Authorized $2.5B Plan,2015-11-06 16:33:00-05:00,ENDP,neutral
422635.0,"Endo Int'l Reports Q3 EPS $1.02 vs est $0.99, Sales $745.7M Vs Est $736.16M",2015-11-05 06:32:00-05:00,ENDP,neutral
422636.0,"OZ Management, Royce & Associates Increase Stakes In Two Companies Ahead Of Earnings",2015-11-03 15:40:00-05:00,ENDP,positive
422637.0,Oz Management  Reports 5.15% Passive Stake In Endo International as of October 21,2015-11-02 16:24:00-05:00,ENDP,positive
422638.0,5 Worst Stock Ideas Of October,2015-11-02 08:26:00-05:00,ENDP,negative
422639.0,BioDelivery Sciences +20% Premarket Following Announcement of $50M Milestone Payment from Endo,2015-10-26 07:03:00-04:00,ENDP,neutral
422640.0,FDA Approval of BELBUCA Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals,2015-10-26 07:00:00-04:00,ENDP,negative
422641.0,Endo International Announces FDA Approval For Buccal Film,2015-10-26 06:05:00-04:00,ENDP,positive
422642.0,FDA Approves BELBUCA Buccal Film for Chronic Pain Management,2015-10-26 06:01:00-04:00,ENDP,negative
422643.0,Endo Provides Update on Use of Specialty Pharmacies,2015-10-21 13:38:00-04:00,ENDP,neutral
422644.0,"Endo International Shares Falling, Trading At $55.68/Share",2015-10-21 10:28:00-04:00,ENDP,positive
422645.0,Swedish Orphan Biovitrum AB Announces Approval of Xiapex by Swissmedic for Treatment of Peyronie's disease in Switzerland,2015-10-16 04:24:00-04:00,ENDP,positive
422646.0,Option Alert: $ENDP Oct $65 Put Sweep; 4020 Contracts @Ask @$0.75; Now $66.12,2015-10-15 15:38:00-04:00,ENDP,positive
422647.0,How To Invest During Biotech's Latest Crisis,2015-10-09 11:25:00-04:00,ENDP,negative
422648.0,Benzinga's Top Initiations,2015-10-09 09:34:00-04:00,ENDP,positive
422649.0,"Mizuho Securities Initiates Coverage on Endo International at Buy, Announces $82.00 PT",2015-10-09 07:22:00-04:00,ENDP,positive
422650.0,"Mizuho Securities Initiates Coverage on Endo International at Buy, Announces $82.00 PT",2015-10-08 19:22:00-04:00,ENDP,positive
422651.0,"Don't Worry Spec. Pharma Investors, Drug Pricing Legislation Probably Won't Affect You",2015-10-05 15:06:00-04:00,ENDP,positive
422652.0,"Worst Performing Industries For October 5, 2015",2015-10-05 11:30:00-04:00,ENDP,negative
422653.0,Hearing Unconfirmed Negative Chatter in Endo,2015-09-30 11:03:00-04:00,ENDP,negative
422654.0,5 Specialty Pharma Stocks Nomura Is Picking To Weather The Storm,2015-09-29 15:27:00-04:00,ENDP,neutral
422655.0,Endo Bought Par In One Of Biggest Generics M&A Deals Ever: What The Street's Saying,2015-09-29 09:57:00-04:00,ENDP,neutral
422656.0,"Nomura Lists AGN, VRX, PCRX, ENDP, & PDHL As Top Picks, Says M&A Remains Value Driver & More Consolidation",2015-09-29 06:28:00-04:00,ENDP,positive
422657.0,10 Stocks Moving In Monday's After-Hours Session,2015-09-28 16:47:00-04:00,ENDP,neutral
422658.0,Endo International Sees FY2016 EPS $5.85-6.15 vs $5.71 Est,2015-09-28 06:34:00-04:00,ENDP,neutral
422659.0,Endo International Sees FY2015 EPS $4.50-4.60 vs $4.52 Est; Sees Sales $3.22B-3.27B vs $2.96B Est,2015-09-28 06:34:00-04:00,ENDP,neutral
422660.0,Par Pharmaceutical Withdraws IPO Due to Acquisition by Endo,2015-09-25 12:25:00-04:00,ENDP,neutral
422661.0,"Endo International,Par Pharmaceuticals Agreed to Divest all Endo's Rights, Assets to Generic Glycopyrrolate Tablets, Generic Methimazole Tablets in Connection With Endo's Acquisition of Par -Reuters",2015-09-25 11:16:00-04:00,ENDP,positive
422662.0,Endo Announces Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Par Pharmaceutical,2015-09-25 06:01:00-04:00,ENDP,neutral
422663.0,"Endo Pharmaceuticals, BioDelivery Sciences Present Promising Data On New Chronic Pain Management Product",2015-09-10 17:17:00-04:00,ENDP,negative
422664.0,Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management,2015-09-09 07:33:00-04:00,ENDP,negative
422665.0,Endo Reports Dr. Craig Paterson Chief Medical Officer,2015-09-08 07:32:00-04:00,ENDP,neutral
422666.0,Benzinga's Top Downgrades,2015-09-01 09:43:00-04:00,ENDP,positive
422667.0,Growth Uncertainty For Endo Continues Through 2017,2015-09-01 08:52:00-04:00,ENDP,positive
422668.0,"Morgan Stanley Downgrades Endo International to Equal-weight, Lowers PT to $85.00",2015-09-01 04:05:00-04:00,ENDP,negative
422669.0,"Endo Pharmaceuticals Reports XIAFLEX for Dupuytren's Contracture Formal Pricing in Japan; Commercial Launch Set for September 16, 2015, First Sale To Trigger $20M Milestone Payment To Endo",2015-08-31 08:02:00-04:00,ENDP,neutral
422670.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,ENDP,neutral
422671.0,Endo Int'l Release Confirms District Court Has Ruled to Uphold OPANA ER IP,2015-08-14 15:31:00-04:00,ENDP,neutral
422672.0,Hearing Endo Health Has Received a Ruling Successfully Blocking Opana Generic Through 2023,2015-08-14 14:16:00-04:00,ENDP,positive
422673.0,Endo Spikes Higher,2015-08-14 14:13:00-04:00,ENDP,neutral
422674.0,4 More Biotechs Leerink Is Looking At Post-Earnings,2015-08-11 14:26:00-04:00,ENDP,neutral
422675.0,Endo International Tops Q2 Estimates,2015-08-10 08:02:00-04:00,ENDP,positive
422676.0,"Endo International Q2 EPS $1.08 vs $1.02 est, Revenue $735M vs $727M est",2015-08-10 06:31:00-04:00,ENDP,neutral
422677.0,"Earnings Scheduled For August 10, 2015",2015-08-10 04:26:00-04:00,ENDP,neutral
422678.0,"RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan",2015-07-29 08:54:00-04:00,ENDP,neutral
422679.0,Benzinga's Top Upgrades,2015-07-17 09:20:00-04:00,ENDP,positive
422680.0,"RBC Capital Upgrades Endo International to Top Pick, Raises PT to $107.00",2015-07-17 06:25:00-04:00,ENDP,positive
422681.0,Endo Shares Move to High on Volume,2015-07-14 10:37:00-04:00,ENDP,positive
422682.0,Top Takeaways From BMO's Specialty Pharma Day,2015-07-01 13:13:00-04:00,ENDP,positive
422684.0,"Stifel Nicolaus Maintains Buy on Endo International, Raises PT to $115.00",2015-06-15 07:15:00-04:00,ENDP,neutral
422685.0,"ARIAD, Paladin Report Commercial Distribution Agreement For Iclusig In Canada",2015-06-10 07:35:00-04:00,ENDP,positive
422686.0,US Stock Futures Slip; All Eyes On Jobs Report,2015-06-05 07:22:00-04:00,ENDP,neutral
422687.0,Endo Prices ~24.02M Share Offering @$83.25/Share,2015-06-05 04:29:00-04:00,ENDP,positive
422688.0,Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere,2015-06-03 17:05:00-04:00,ENDP,neutral
422689.0,Raymond James Initiates Coverage on Endo International at Market Perform,2015-06-03 06:32:00-04:00,ENDP,neutral
422690.0,Endo Int'l Reports Proposed Public Offering of $1.75B Ordinary Shares,2015-06-02 17:37:00-04:00,ENDP,positive
422691.0,Filing from Endo Int'l Shows Registration for Automatic Mixed Securities Shelf Offering,2015-06-02 17:31:00-04:00,ENDP,positive
422692.0,Billionaire-Tracking ETF Just Bulked Up On Health Care,2015-05-24 16:07:00-04:00,ENDP,positive
422693.0,Valeant CEO: Healthcare Sector A 'Bit Of A Bubble',2015-05-22 10:34:00-04:00,ENDP,neutral
422694.0,7 Biotech Stocks Moving Off The UBS Healthcare Conference,2015-05-19 14:16:00-04:00,ENDP,neutral
422695.0,From Conf Call: Endo International CEO Says Will Be Looking for Deals On Lower End of Range of $300M to $1B,2015-05-18 09:19:00-04:00,ENDP,negative
422696.0,More Waves In Pharma: Endo Buys TPG Capital's Par Pharma for $8 Billion,2015-05-18 08:58:00-04:00,ENDP,neutral
422697.0,"Endo to Acquire Par Pharmaceutical, for 18M Shares, $6.5B in Cash",2015-05-18 06:32:00-04:00,ENDP,positive
422698.0,Endo To Acquire Par Pharmaceutical,2015-05-18 06:30:00-04:00,ENDP,neutral
422699.0,"Endo Pharma, BioDelivery Sciences Reports Presentation of Pivotal Data from Two Phase 3 Trials Showing Safety, Efficacy of Buprenorphine HCl Buccal Film for Chronic Pain",2015-05-14 16:22:00-04:00,ENDP,negative
422700.0,Leerink Is Changing Targets At These 7 Biotechs,2015-05-12 12:54:00-04:00,ENDP,neutral
422701.0,"Endo Posts Upbeat Q1 Earnings, Lifts FY15 Forecast",2015-05-11 09:21:00-04:00,ENDP,neutral
422702.0,"Endo Int'l Reports Purchase of Portfolio of Branded, Generic Products from Unit of Aspen Holdings; No Terms Disclosed",2015-05-11 07:32:00-04:00,ENDP,negative
422703.0,Endo Int'l Raises FY15 EPS Outlook from $4.35-$4.55 Previously to $4.40-$4.60 vs $4.48 Est.,2015-05-11 07:15:00-04:00,ENDP,neutral
422704.0,"Endo Health Q1 EPS $1.17 vs $1.06 est, Revenue $714.1M vs $714.4M est",2015-05-11 07:02:00-04:00,ENDP,neutral
422705.0,"Earnings Scheduled For May 11, 2015",2015-05-11 04:04:00-04:00,ENDP,neutral
422706.0,Endo Names Matthew J. Maletta as Chief Legal Officer,2015-04-28 08:06:00-04:00,ENDP,positive
422707.0,Endo IR Says Co Has Not Cancelled Out of Any Conference,2015-04-13 13:46:00-04:00,ENDP,positive
422708.0,Endo Shares Volatile on Unconfirmed Market Chatter They have Cancelled Out of Upcoming Conference,2015-04-13 13:24:00-04:00,ENDP,negative
422709.0,3 JPMorgan Bull Calls Hitting The Market,2015-04-02 14:25:00-04:00,ENDP,neutral
422710.0,"JP Morgan Reinstates Overweight on Endo International, Announces $105.00 PT",2015-04-02 06:54:00-04:00,ENDP,neutral
422711.0,"Benzinga's M&A Chatter for Monday March 16, 2015",2015-03-16 19:11:00-04:00,ENDP,neutral
422712.0,"FTC Has Approved Valeant, Salix Deal",2015-03-16 11:12:00-04:00,ENDP,positive
422713.0,Morning Market Gainers,2015-03-16 09:40:00-04:00,ENDP,neutral
422714.0,Endo Announces Withdrawal of Bid for Salix,2015-03-16 09:23:00-04:00,ENDP,neutral
422715.0,"Valeant Raises Salix Bid, Agree To All-Cash Deal",2015-03-16 08:41:00-04:00,ENDP,positive
422716.0,WSJ Breaking News Tweets: 'Valeant and Salix agree to cash deal valuing Salix $173 per share',2015-03-16 07:55:00-04:00,ENDP,positive
422717.0,Hearing Valeant Has Increased Bid for Salix to $173/Share,2015-03-16 07:50:00-04:00,ENDP,positive
422718.0,Endo Pharma Reports Launch of NATESTO,2015-03-16 07:32:00-04:00,ENDP,neutral
422719.0,Benzinga's Weekend M&A Chatter,2015-03-15 18:27:00-04:00,ENDP,neutral
422720.0,"Endo Says it Can Close Salix Acquisition in as Little as Five Weeks Following Negotiated Deal, According to Email -Reuters",2015-03-15 18:08:00-04:00,ENDP,neutral
422721.0,Valeant Reportedly Planning To Raise Bid For Salix; Working With Pershing Square & ValueAct Capital To Finance Offer,2015-03-13 14:58:00-04:00,ENDP,neutral
422722.0,UPDATE: NY Times Reports Valeant to Raise Bid for Salix,2015-03-13 13:41:00-04:00,ENDP,neutral
422723.0,UPDATE: Spike in Valeant May be Attributed to Value Walk Report: 'Why Valeant Could Match And Beat Endo's Offer To Buy Salix',2015-03-13 13:36:00-04:00,ENDP,positive
422724.0,At Barclays Event: ENDO CEO Eyes Other Possible Opportunities If Salix Deal Falls Apart,2015-03-12 14:40:00-04:00,ENDP,positive
422725.0,"Why Valeant, Not Endo, Could Still Win The War For Salix",2015-03-12 13:54:00-04:00,ENDP,neutral
422726.0,William Blair Says Cash Is King In Salix Bidding War,2015-03-12 13:28:00-04:00,ENDP,negative
422727.0,Option Alert: Salix Apr $170 Call; 1000 Contract Trade between Bid/Ask @$3.70,2015-03-12 09:54:00-04:00,ENDP,positive
422728.0,"Benzinga's M&A Chatter for Wednesday March 11, 2015",2015-03-11 19:41:00-04:00,ENDP,neutral
422729.0,Salix Confirms Receipt Of Unsolicited Proposal From Endo; Will Review & Consider,2015-03-11 15:19:00-04:00,ENDP,neutral
422730.0,ENDO Sends Salix Non-Binding Proposal Letter,2015-03-11 14:56:00-04:00,ENDP,neutral
422731.0,ENDO Trading Resumed At 15:05:00,2015-03-11 14:52:00-04:00,ENDP,neutral
422732.0,UPDATE: Terms For Endo Deal For Salix Consists Of 1.4607 ENDP Shares And $45/Share Cash,2015-03-11 14:34:00-04:00,ENDP,positive
422733.0,Endo Sees Deal Completion With Salix By Q2 2015,2015-03-11 14:33:00-04:00,ENDP,neutral
422734.0,UPDATE: Endo Deal To Be A Combination Of Cash & Stock,2015-03-11 14:32:00-04:00,ENDP,neutral
422735.0,Endo Confirms Proposal To Acquire Salix For $175/Share,2015-03-11 14:29:00-04:00,ENDP,neutral
422736.0,Hearing Faber Says Endo/Salix Offer Has $350M Breakup Fee,2015-03-11 14:21:00-04:00,ENDP,neutral
422737.0,DAVID FABER @davidfaber Tweet: ENDO bid is above $165 for $SLXP. Sorry if said otherwise on air. Will be 25% in cash. Will require $ENDP shareholder vote. Close late June.,2015-03-11 14:10:00-04:00,ENDP,negative
422738.0,CNBC's David Faber Tweets: 'ENDO bid is above $165 for $SLXP. Sorry if said otherwise on air. Will be 25% in cash. Will require $ENDP shareholder vote. Close late June.',2015-03-11 14:10:00-04:00,ENDP,negative
422739.0,ENDO Said To Plan On Making Salix Offer As Soon As Today,2015-03-11 13:55:00-04:00,ENDP,neutral
422740.0,"Endo Shares Halted, News Pending",2015-03-11 13:45:00-04:00,ENDP,positive
422741.0,Bloomberg Now Reporting ENDO will Make Bid To Salix In $170-$175 Range,2015-03-11 13:44:00-04:00,ENDP,neutral
422742.0,Endo Bidding $170/Share For Salix,2015-03-11 13:26:00-04:00,ENDP,neutral
422743.0,"Valeant to Continue With $9.6B Bond Offering Despite Rumored Endo Bid for Salix, According to Source",2015-03-11 13:14:00-04:00,ENDP,neutral
422744.0,Endo Sent E-Mail To Salix Offering $165/Share,2015-03-11 13:08:00-04:00,ENDP,neutral
422745.0,UPDATE: Endo Reportedly Bidding More than $165/Share for Salix,2015-03-11 12:48:00-04:00,ENDP,neutral
422746.0,"UPDATE: WSJ's Deals Editor Jamie Heller Tweets: 'WSJ scoop: Endo makes takeover offer for Salix, seeking to wrest company from Valeant. $ENDP $SLXP $VRX'",2015-03-11 12:46:00-04:00,ENDP,positive
422747.0,"Endo Makes Takeover Offer For Salix, Accoring to Sources -WSJ",2015-03-11 12:41:00-04:00,ENDP,neutral
422748.0,UPDATE: Morgan Stanley Resumes Coverage On Endo International On Durable Growth And M&A Optionality,2015-03-05 10:07:00-05:00,ENDP,positive
422749.0,"Morgan Stanley Reinstates Overweight on Endo International, Announces $101.00 PT",2015-03-05 07:59:00-05:00,ENDP,negative
422750.0,Analyst: Boston Scientific's Acquisition Is 'Strategically Sound',2015-03-03 16:10:00-05:00,ENDP,neutral
422751.0,"Benzinga's M&A Chatter for Monday March 2, 2015",2015-03-02 19:29:00-05:00,ENDP,neutral
422752.0,"'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals",2015-03-02 13:19:00-05:00,ENDP,neutral
422753.0,UPDATE: Endo Tops Q4 Views,2015-03-02 08:44:00-05:00,ENDP,positive
422754.0,CORRECTION: Endo Health Reports Q4 Adj. EPS $1.16 vs $1.12 Est.,2015-03-02 07:21:00-05:00,ENDP,neutral
422755.0,Boston Scientific To Buy Endo Unit For ~$1.65B,2015-03-02 07:03:00-05:00,ENDP,neutral
422756.0,Endo Announces Divestiture of American Medical Systems' Men's And Prostate Health Businesses to Boston Scientific for Up to $1.65B,2015-03-02 07:02:00-05:00,ENDP,neutral
422757.0,Endo Health Reports Q4 EPS $1.16 vs Est $1.12,2015-03-02 07:01:00-05:00,ENDP,neutral
422758.0,"Earning & Economic Calendar for Monday March 2, 2015",2015-03-02 04:51:00-05:00,ENDP,neutral
422759.0,"Earnings Scheduled For March 2, 2015",2015-03-02 04:44:00-05:00,ENDP,neutral
422760.0,"Benzinga's M&A Chatter for Tuesday February 24, 2015",2015-02-24 18:03:00-05:00,ENDP,neutral
422761.0,"Boston Scientific Near Deal to Acquire Endo's AMS Medical Device Unit, According to Sources -Reuters",2015-02-24 12:14:00-05:00,ENDP,neutral
422762.0,"Endo Pharma, BioDelivery Sciences Reports Acceptance of NDA for Belbuca",2015-02-23 07:31:00-05:00,ENDP,positive
422763.0,"American Medical Reports 1,000th Patient Enrolled In PROPPER Registry",2015-02-19 16:31:00-05:00,ENDP,neutral
422764.0,"Citigroup Reinstates Buy on Endo International, Announces $98.00 PT",2015-02-19 06:27:00-05:00,ENDP,neutral
422765.0,Benzinga's Weekend M&A Chatter,2015-02-16 17:14:00-05:00,ENDP,neutral
422766.0,"Endo Has Expressed Interest in Salix Pharmaceuticals, According to Source -Reuters",2015-02-13 15:59:00-05:00,ENDP,positive
422767.0,"Standard & Poors Announces Endo Int'l to Replace Covidien in S&P 500, Boost Beer Will Replace Endo in S&P MidCap 400, Southside Bancshares to Replace Boston Beer",2015-01-21 17:20:00-05:00,ENDP,positive
422768.0,Endo International plc Announces Proposed Private Offering Of Senior Notes,2015-01-20 08:45:00-05:00,ENDP,neutral
422769.0,"Endo International Plc Announces Retirement Of Chief Legal Officer, EVP Caroline Manogue",2015-01-05 16:36:00-05:00,ENDP,positive
422770.0,Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain,2014-12-23 16:15:00-05:00,ENDP,negative
422771.0,Trimel Announces Closing of Exclusive Agreement for NATESTO with Endo Affiliate,2014-12-09 07:15:00-05:00,ENDP,positive
422772.0,US Stock Futures Up Ahead Of Economic Data,2014-11-24 07:20:00-05:00,ENDP,neutral
422773.0,UPDATE: FDA-Approved Product Further Expands Endo's Branded Pharmaceutical Men's Health Portfolio,2014-11-24 07:02:00-05:00,ENDP,positive
422774.0,FDA-Approved Product Further Expands Endo's Branded Pharmaceutical Men's Health Portfolio,2014-11-24 07:01:00-05:00,ENDP,positive
422775.0,Endo Int'l Reports Launch of Generic Valcyte,2014-11-20 07:34:00-05:00,ENDP,neutral
422776.0,Endo Announces Early Termination of HSR Act Waiting Period In Connection With Its Proposed Acquisition of Auxilium Pharmaceuticals,2014-11-19 07:32:00-05:00,ENDP,neutral
422777.0,Endo Reports Receiving of Final Approval for Generic Version of Valcyte,2014-11-10 08:19:00-05:00,ENDP,positive
422778.0,Endo Health Solutions Inc. Reports Q3 EPS of $1.15 vs $0.99 Est; Revenue of $763.90M vs $721.11M Est,2014-11-05 07:03:00-05:00,ENDP,positive
422779.0,"Earnings Scheduled For November 5, 2014",2014-11-05 05:05:00-05:00,ENDP,neutral
422780.0,Benzinga's Top Initiations,2014-10-23 09:17:00-04:00,ENDP,positive
422781.0,Guggenheim Securities Initiates Endo Health Solutions With Buy,2014-10-23 06:23:00-04:00,ENDP,positive
422782.0,"CORRECTION: Guggenheim Securities Initiates Coverage on Endo Health Solutions Inc. at Buy, Announces $80.00 PT",2014-10-23 05:51:00-04:00,ENDP,positive
422783.0,"Guggenheim Securities Initiates Coverage on Endo Health Solutions Inc. at Buy, Announces $80.00 PT",2014-10-23 05:50:00-04:00,ENDP,positive
422784.0,Sterne Agee Sees Entry Point In Endo International PLC Shares,2014-10-14 15:51:00-04:00,ENDP,positive
422785.0,Cantor Fitzgerald Upgrades Endo Health Solutions Inc. to Hold,2014-10-13 06:41:00-04:00,ENDP,positive
422786.0,UPDATE: Mizuho Securities Downgrades Auxilium Pharmaceuticals,2014-10-10 14:56:00-04:00,ENDP,positive
422787.0,"Benzinga's M&A Chatter for Thursday October 9, 2014",2014-10-09 19:33:00-04:00,ENDP,neutral
422788.0,"Dow Suffers Worst One-Day Performance In 2014, Volatility Returns To The Markets",2014-10-09 16:55:00-04:00,ENDP,negative
422789.0,"Top Performing Industries For October 9, 2014",2014-10-09 10:57:00-04:00,ENDP,positive
422790.0,Benzinga's Volume Movers ,2014-10-09 10:50:00-04:00,ENDP,neutral
422791.0,Morning Market Movers ,2014-10-09 09:41:00-04:00,ENDP,neutral
422792.0,Benzinga's Top #PreMarket Gainers,2014-10-09 08:06:00-04:00,ENDP,positive
422793.0,US Stock Futures Mixed Ahead Of Jobless Claims Data,2014-10-09 07:26:00-04:00,ENDP,neutral
422794.0,"UPDATE: Endo to Acquire Auxilium Pharmaceuticals for $33.25/Share in Cash, Stock Deal",2014-10-09 06:33:00-04:00,ENDP,neutral
422795.0,"Endo To Acquire Auxilium Pharmaceuticals for ~$2.6B in Cash, Stock",2014-10-09 06:31:00-04:00,ENDP,neutral
422796.0,Endo Reports Master Settlement Deals to Resolve 'Substantially All Remaining AMS Mesh Litigation Claims',2014-09-30 17:09:00-04:00,ENDP,positive
422797.0,"Option Alert: Endo Nov $70 Call; 3,000 Contract Trade at Ask @$4.10; Currently $69.36",2014-09-29 15:21:00-04:00,ENDP,positive
422798.0,US Stock Futures Decline Ahead Of Home Sales Report,2014-09-22 07:38:00-04:00,ENDP,neutral
422799.0,Auxilium Says Endo Proposal Not Superior to Merger Agreement with QLT,2014-09-22 07:05:00-04:00,ENDP,positive
422800.0,"Benzinga's M&A Chatter for Wednesday September 17, 2014",2014-09-17 20:41:00-04:00,ENDP,neutral
422801.0,FDA Spokesperson Confirms FDA Advisory Panel Has Voted 20-1 FDA Should Revise Approved Uses of Testosterone Treatments,2014-09-17 17:09:00-04:00,ENDP,positive
422802.0,Stocks Gain On Federal Reserve Update,2014-09-17 16:50:00-04:00,ENDP,positive
422803.0,Several Sources on Twitter Suggesting FDA Advisory Panel Has Voted 20-1 FDA Needs to Revise Approved Uses for Testosterone Drugs,2014-09-17 16:45:00-04:00,ENDP,positive
422804.0,U.S. Stocks Gain After Fed Statement; General Mills Shares Fall On Downbeat Results,2014-09-17 15:29:00-04:00,ENDP,positive
422805.0,Lennar Gains On Upbeat Earnings; Adobe Shares Slide,2014-09-17 12:37:00-04:00,ENDP,positive
422806.0,Markets Gain; FedEx Profit Beats Street View,2014-09-17 11:14:00-04:00,ENDP,positive
422807.0,"Top Performing Industries For September 17, 2014",2014-09-17 10:27:00-04:00,ENDP,positive
422808.0,Benzinga's Volume Movers,2014-09-17 10:17:00-04:00,ENDP,neutral
422809.0,Morning Market Movers ,2014-09-17 09:38:00-04:00,ENDP,neutral
422810.0,Benzinga's Top #PreMarket Gainers,2014-09-17 08:08:00-04:00,ENDP,positive
422811.0,"Auxilium Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Proposal from Endo; Will Review Proposal; Adopts 1-Year Stockholder Rights Plan",2014-09-17 07:05:00-04:00,ENDP,positive
422812.0,"Stocks To Watch For September 17, 2014",2014-09-17 04:08:00-04:00,ENDP,neutral
422813.0,"Benzinga's M&A Chatter for Tuesday September 16, 2014",2014-09-16 19:29:00-04:00,ENDP,neutral
422814.0,"Auxilium Pharmaceuticals, Inc. Gets $2.2 Billion Unsolicited Bid",2014-09-16 17:42:00-04:00,ENDP,neutral
422815.0,"UPDATE: Endo Offers to Buy Auxilium Pharma at $28.10/Share in Cash, Stock",2014-09-16 16:48:00-04:00,ENDP,neutral
422816.0,"Shares of Endo Int'l Now Up ~5% Following $28.10/Share Cash, Stock Bid for Auxilium, Auxilium Shares Jump ~5% Before Being Halted",2014-09-16 16:47:00-04:00,ENDP,positive
422817.0,Shares of Auxilium Pharma Halted Following Press Release Disclosing Endo Bid,2014-09-16 16:46:00-04:00,ENDP,positive
422818.0,"Endo Offers to Buy Auxilium Pharma at $28.10/Share in Cash, Stock",2014-09-16 16:45:00-04:00,ENDP,neutral
422819.0,Endo Int'l's American Medical Systems Unit Reports Top-Line Data on Study of TOPAS Shows Improved Fecal Incontinence in Women,2014-09-08 16:34:00-04:00,ENDP,positive
422820.0,Endo Int'l Reports Introduction of Authorized Generic of FORTESTA Gel,2014-09-08 07:33:00-04:00,ENDP,neutral
422821.0,Benzinga's Top Initiations,2014-09-02 09:16:00-04:00,ENDP,positive
422822.0,RBC Capital Initiates Endo Health At Outperform,2014-09-02 07:42:00-04:00,ENDP,neutral
422823.0,"RBC Capital Initiates Coverage on Endo Health Solutions Inc. at Outperform, Announces $80.00 PT",2014-09-02 05:56:00-04:00,ENDP,positive
422824.0,Endo Health Solutions Inc. Raises FY2014 EPS Guidance from $3.80-4.00 to $4.00-4.20 vs $3.97 Est; Raises FY2014 Sales Guidance from $2.72B-2.80B to $2.78B-2.86B vs $2.76B Est,2014-08-06 17:11:00-04:00,ENDP,positive
422825.0,Endo Health Solutions Inc. Raises FY2014 EPS Guidance from $3.60-3.85 to $3.80-4.00 vs $3.77 Est; Raises FY2014 Sales Guidance from $2.55B-2.64B to $2.72B-2.80B vs $2.63B Est,2014-07-31 06:33:00-04:00,ENDP,positive
422826.0,Endo Health Solutions Inc. Reports Q2 EPS of $1.06 Which May Not Compare $0.89 Est; Revenue of $718.70M Which May Not Compare $647.04M Est,2014-07-31 06:32:00-04:00,ENDP,positive
422827.0,Endo's Paladin Labs Reports Canadian Introduction Of Veregen ,2014-07-16 07:40:00-04:00,ENDP,neutral
422828.0,UPDATE: BioDelivery Sciences Shares RIse 18% Premarket on Positive Top-Line Phase III Results ,2014-07-07 07:25:00-04:00,ENDP,positive
422829.0,"Canaccord Genuity Initiates Coverage on Endo Health Solutions Inc. at Buy, Announces $83.00 PT",2014-06-27 06:53:00-04:00,ENDP,positive
422830.0,"Benzinga's M&A Chatter for Tuesday June 24, 2014",2014-06-24 17:53:00-04:00,ENDP,neutral
422831.0,Endo International to Acquire DAVA Pharma For $575M Cash and Up to $25M in Milestone Payments,2014-06-24 09:10:00-04:00,ENDP,neutral
422832.0,Endo Hires PricewaterhouseCoopers as Accounting Firm,2014-06-13 06:34:00-04:00,ENDP,neutral
422833.0,Wells Fargo Initiates Coverage On The Pharmaceutical Space,2014-06-11 11:36:00-04:00,ENDP,positive
422834.0,Wells Fargo Initiates Coverage on Endo Health Solutions Inc. at Outperform,2014-06-11 06:21:00-04:00,ENDP,positive
422835.0,Endo Int'l Closes Sale of Early Stage Drug Discovery Portfolio,2014-06-02 07:38:00-04:00,ENDP,neutral
422836.0,Endo Int'l Closes Sale of Early Stage Drug Discovery Portfolio,2014-06-02 07:38:00-04:00,ENDP,neutral
422837.0,"UPDATE: Zogenix Announces Closing of Sale of SUMAVEL DosePro Migraine Therapy to Endo Int'l, Zogenix Repaid $40M in Debt to Healthcare Royalty Partners",2014-05-19 07:36:00-04:00,ENDP,negative
422838.0,"Zogenix Announces Closing of Sale of SUMAVEL DosePro Migraine Therapy to Endo Int'l, Zogenix Repaid $40M in Debt to Healthcare Royalty Partners",2014-05-19 07:33:00-04:00,ENDP,negative
422839.0,UPDATE: Morgan Stanley Upgrades Endo International PLC On Attractive Risk-Reward,2014-05-02 10:14:00-04:00,ENDP,positive
422840.0,"Morgan Stanley Upgrades Endo Health Solutions Inc. to Overweight, Announces $79.00 PT",2014-05-02 07:53:00-04:00,ENDP,negative
422841.0,Morgan Stanley Upgrades Endo Health Solutions Inc. to Overweight,2014-05-02 07:40:00-04:00,ENDP,negative
422842.0,Sterne Agee Sees Good Things Ahead for Endo International PLC,2014-05-01 08:10:00-04:00,ENDP,positive
422843.0,Endo Health Solutions Reports Q1 Adjusted EPS of $0.92 vs $0.84 Est; Revenue of $594.60M vs $608.86M Est,2014-05-01 06:12:00-04:00,ENDP,positive
422844.0,"Earnings Scheduled For May 1, 2014",2014-05-01 05:36:00-04:00,ENDP,neutral
422845.0,Endo Reaches $830M Settlement on Majority of AMS Litigation Cases,2014-04-30 16:32:00-04:00,ENDP,negative
422846.0,"Endo to Acquire Grupo Farmaceutico, No Terms Disclosed",2014-04-29 08:32:00-04:00,ENDP,negative
422847.0,Morning Market Movers ,2014-04-24 09:42:00-04:00,ENDP,neutral
422848.0,Benzinga's Top #PreMarket Gainers,2014-04-24 08:11:00-04:00,ENDP,positive
422849.0,"Zogenix Announces Sale of SUMAVEL DosePro Migraine Therapy to Endo International for $85M, Up to $20M Milestone Payments",2014-04-24 07:31:00-04:00,ENDP,neutral
422850.0,"Sterne Agee Initiates Coverage on Endo Health Solutions Inc. at Buy, Announces $66.00 PT",2014-04-16 08:25:00-04:00,ENDP,positive
422851.0,Endo's American Medical Systems Unit Receives FDA Warning Letter Regarding Minnesota Facility; Unit Has 15 Days to Respond ,2014-04-16 07:14:00-04:00,ENDP,negative
422852.0,"Endo Health Reports Extension of Consent Date, Exchange Offer Will Now Expire Apr. 28th",2014-04-11 08:03:00-04:00,ENDP,positive
422853.0,"Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related to Generic FROVA",2014-04-11 07:31:00-04:00,ENDP,neutral
422854.0,Morgan Stanley Sees Possible Upside Source for Endo International PLC,2014-04-10 09:58:00-04:00,ENDP,neutral
422855.0,Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane in Canada,2014-04-10 08:05:00-04:00,ENDP,positive
422856.0,"Option Alert: Endo Jul $80 Call; 6,010 Contracts Traded vs 1,495 OI: Currently $67.45",2014-04-02 14:43:00-04:00,ENDP,positive
422857.0,Endo Names Dr. Susan Hall as New Chief Scientific Officer,2014-03-07 07:33:00-05:00,ENDP,neutral
422858.0,Market Wrap For March 6: Investors Find Positives In Jobless Claims,2014-03-06 17:06:00-05:00,ENDP,positive
422859.0,Endo Announces FDA Approves AVEED Injectable Testosterone Replacement Therapy for Men With Hypogonadism,2014-03-06 07:07:00-05:00,ENDP,positive
422860.0,Endo Pharma Wins FDA Approval for Aveed - Bloomberg,2014-03-05 14:55:00-05:00,ENDP,positive
422861.0,Morgan Stanley Updates Estimates On Endo Health Solutions,2014-03-03 10:07:00-05:00,ENDP,positive
422862.0,"CRT Capital Maintains Fair Value on Endo Health Solutions Inc., Raises PT to $73.00",2014-03-03 08:55:00-05:00,ENDP,positive
422863.0,Market Wrap For February 28: Markets Unable To Hold On To Gains,2014-02-28 16:53:00-05:00,ENDP,positive
422864.0,Endo Health Solutions Reports Q4 Adjusted EPS of $0.96 vs $0.93 Est; Revenue of $584.90M vs $620.74M Est,2014-02-28 06:04:00-05:00,ENDP,positive
422865.0,"Earnings Scheduled For February 28, 2014",2014-02-28 04:58:00-05:00,ENDP,neutral
422866.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio ,2014-02-28 04:30:00-05:00,ENDP,negative
422867.0,UPDATE: Endo Is IN a DPA with DoJ for Up to 2.5 Years,2014-02-21 12:50:00-05:00,ENDP,neutral
422868.0,"Endo Pharma Confirms Resolution of Gov't Probe, Says Will Pay Up to $194M",2014-02-21 12:50:00-05:00,ENDP,negative
422869.0,New York Attorney General Announces $173M Settlement with Endo Pharma,2014-02-21 12:20:00-05:00,ENDP,neutral
422870.0,Endo Health Solutions Announces 2013 Non-Cash Pretax Charges $495M ,2014-02-19 07:31:00-05:00,ENDP,negative
422871.0,Endo Completes Divestiture Of HealthTronics for Total Consideration up to $130M ,2014-02-03 16:02:00-05:00,ENDP,neutral
422872.0,Endo Confirms Court Upholds FROVA Patent,2014-01-29 16:41:00-05:00,ENDP,neutral
422873.0,BioDelivery Sciences Rises 31% Premarket on Positive Top-Line Results from the Phase III Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain,2014-01-24 07:51:00-05:00,ENDP,negative
422874.0,Top Gainers After Hours,2014-01-23 17:13:00-05:00,ENDP,positive
422875.0,"Endo Pharma, BioDelivery Sciences Report Top-Line Results from Phase III Trial of BEMA Buprenorphine",2014-01-23 16:32:00-05:00,ENDP,neutral
422876.0,UPDATE: Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain,2014-01-23 16:31:00-05:00,ENDP,negative
422877.0,"Benzinga's M&A Chatter for Tuesday January 21, 2014",2014-01-21 18:06:00-05:00,ENDP,neutral
422878.0,NuPathe Terminates Merger Agreement with Endo ,2014-01-21 07:03:00-05:00,ENDP,positive
422879.0,"Morgan Stanley Maintains Equal-weight on Endo Health Solutions Inc.to Equal-weight, Removes $53.00 PT",2014-01-17 06:43:00-05:00,ENDP,positive
422880.0,"Form 8-K from Endo Health Shows Co. Expecting Pretax Impairment Charge $110M in Q4, Sees Added Charge Equal to Expected Loss on Sale",2014-01-09 17:24:00-05:00,ENDP,negative
422881.0,"Endo Reports Divestiture of HealthTronics for Up to $130M to Altaris Capital, Will Get upfront Cash Payment of $85M, Has Added Cash Payment Consideration of Up to $45M",2014-01-09 08:02:00-05:00,ENDP,neutral
422882.0,Market Wrap For January 8: Fed Minutes Released,2014-01-08 16:39:00-05:00,ENDP,neutral
422883.0,"Cantor Fitzgerald Downgrades Endo Health Solutions Inc. to Sell, Lowers PT to $43.00",2014-01-02 07:26:00-05:00,ENDP,positive
422884.0,Endo Announces Early Termination of HSR Act Waiting Period in Connection with Its Proposed Acquisition of Paladin Labs ,2013-12-19 10:14:00-05:00,ENDP,neutral
422885.0,"Benzinga's M&A Chatter for Monday December 16, 2013",2013-12-16 18:30:00-05:00,ENDP,neutral
422886.0,Merger Monday Lives Up To Its Name: More Than $33B In Deals Announced,2013-12-16 15:41:00-05:00,ENDP,neutral
422887.0,Morning Market Movers ,2013-12-16 10:04:00-05:00,ENDP,neutral
422888.0,Benzinga's Top #PreMarket Gainers,2013-12-16 08:16:00-05:00,ENDP,positive
422889.0,Nupathe Resumes Trading,2013-12-16 07:31:00-05:00,ENDP,neutral
422890.0,PREVIEW: NuPathe to Resume Trading at 7:30 AM ET,2013-12-16 07:18:00-05:00,ENDP,neutral
422891.0,NuPathe Shares Halted Ahead of Endo Acquisition Announcement,2013-12-16 07:03:00-05:00,ENDP,positive
422892.0,Endo to Acquire NuPathe for $2.85/Share in Cash,2013-12-16 07:01:00-05:00,ENDP,neutral
422893.0,Endo Health Solution's American Medical Systems Wins FDA 510(k) Clearance of RetroArc,2013-12-09 18:07:00-05:00,ENDP,positive
422894.0,UPDATE: Citigroup Reiterates on Endo Health Solutions on Potential of Paladin Acquisition,2013-11-12 11:34:00-05:00,ENDP,positive
422895.0,DJ Reporting FDA Has Proposed Letting Generic Drugmakers Change Labels,2013-11-08 11:40:00-05:00,ENDP,neutral
422896.0,Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates,2013-11-07 04:19:00-05:00,ENDP,positive
422897.0,UPDATE: Piper Jaffray Upgrades Endo Health Solutions as Paladin Transaction is a Game-Changer,2013-11-06 10:47:00-05:00,ENDP,positive
422898.0,Janney Capital Upgrades Endo Health Solutions Inc. to Neutral,2013-11-06 08:46:00-05:00,ENDP,positive
422899.0,Benzinga's Top Upgrades,2013-11-06 08:02:00-05:00,ENDP,positive
422900.0,Needham Upgrades Endo Health Solutions Inc. to Hold,2013-11-06 07:41:00-05:00,ENDP,positive
422901.0,Cantor Fitzgerald Upgrades Endo Health Solutions Inc. to Hold,2013-11-06 07:40:00-05:00,ENDP,positive
422902.0,"Piper Jaffray Upgrades Endo Health Solutions Inc. to Neutral, Raises PT to $58.00",2013-11-06 06:37:00-05:00,ENDP,positive
422903.0,"Benzinga's M&A Chatter for Tuesday November 5, 2013",2013-11-05 19:08:00-05:00,ENDP,neutral
422904.0,"Piper Jaffray Upgrades Endo Health Solutions Inc. to Neutral, Raises PT to $58.00",2013-11-05 18:04:00-05:00,ENDP,positive
422905.0,Mid-Afternoon Market Update: Marvell Rises on KKR Stake While Orbitz Gives Up Last Week's Gains,2013-11-05 15:23:00-05:00,ENDP,positive
422906.0,Cowen & Company Upgrades Endo Health Solutions Inc. to Market Perform,2013-11-05 13:44:00-05:00,ENDP,positive
422907.0,Mid-Day Market Update: BroadSoft Drops On Q3 Results; Endo Health Shares Spike Higher,2013-11-05 12:29:00-05:00,ENDP,positive
422908.0,Mid-Morning Market Update: Markets Open Lower; CVS Caremark Lifts Outlook,2013-11-05 10:36:00-05:00,ENDP,negative
422909.0,Benzinga's Top #PreMarket Gainers,2013-11-05 08:11:00-05:00,ENDP,positive
422910.0,UPDATE: Endo Health Shares Rise 19% Pre-Market on Paladin Acquisition ,2013-11-05 07:50:00-05:00,ENDP,positive
422911.0,US Stock Futures Signal Lower Start On Wall Street,2013-11-05 07:11:00-05:00,ENDP,negative
422912.0,"Endo to Acquire Paladin Labs for $1.6B in Cash, Stock Deal",2013-11-05 06:38:00-05:00,ENDP,neutral
422913.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2013-10-07 04:38:00-04:00,ENDP,positive
422914.0,"Goldman Sachs Reinstates Buy on Endo Health Solutions Inc., Announces $52.00 PT",2013-09-17 07:07:00-04:00,ENDP,positive
422915.0,UPDATE: FDA Will Be Holding an Official Briefing at 12:45PM EDT to Discuss an Undisclosed Topic,2013-09-10 12:07:00-04:00,ENDP,neutral
422916.0,FDA Traders Considering Admin. Updates Labels on Long-Acting Painkillers,2013-09-10 12:04:00-04:00,ENDP,neutral
422917.0,Endo Health Solutions Names Suketu Upadhyay as New CFO,2013-09-09 08:02:00-04:00,ENDP,positive
422918.0,"Endo Pharma Reports FDA Has Accepted Complete Response Submission to NDA for Aveed Injection, Sets PDUFA Date as Feb. 28, 2014",2013-09-05 08:03:00-04:00,ENDP,positive
422919.0,"Endo, BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Program",2013-09-04 06:31:00-04:00,ENDP,neutral
422920.0,Endo Health Solutions to Buy Boca Pharmacal for $225M,2013-08-28 08:02:00-04:00,ENDP,positive
422921.0,"Endo Health, Metamark Announce Sale of HealthTronics Lab Solutions, No Terms Disclosed",2013-08-12 16:05:00-04:00,ENDP,negative
422922.0,"Citigroup Initiates Coverage on Endo Health Solutions Inc. at Buy, Announces $43.00 PT",2013-08-08 06:35:00-04:00,ENDP,positive
422923.0,"Janney Capital Downgrades Endo Health Solutions Inc. to Sell, Lowers PT to $28.50",2013-08-07 09:35:00-04:00,ENDP,positive
422924.0,Endo Health Solutions Inc. Raises FY2013 EPS Guidance from $4.10-4.40 to $4.25-4.55,2013-08-06 09:12:00-04:00,ENDP,positive
422925.0,Endo Health Solutions Inc. Reports Q2 EPS of $1.42 vs $1.15 Est; Revenue of $766.50M vs $721.01M Est,2013-08-06 09:09:00-04:00,ENDP,positive
422926.0,Benzinga's Top Initiations,2013-07-24 08:37:00-04:00,ENDP,positive
422927.0,"Morgan Stanley Initiates Coverage on Endo Health Solutions Inc. at Equalweight, Announces $40.00 PT",2013-07-24 08:23:00-04:00,ENDP,positive
422928.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2013-07-15 05:09:00-04:00,ENDP,positive
422929.0,ViroPharma and Other Biotech Stocks Recommended by Oppenheimer (VPHM),2013-06-24 15:16:00-04:00,ENDP,positive
422930.0,UPDATE: Oppenheimer Assumes Endo Health Solutions at Perform on Operational Restructuring,2013-06-21 08:37:00-04:00,ENDP,positive
422931.0,"Endo Health Solutions Enters Master Settlement Pact, Will Pay $54.5 Million In Settlement",2013-06-20 17:27:00-04:00,ENDP,positive
422932.0,Oppenheimer Reinstates Perform on Endo Health Solutions Inc.,2013-06-20 16:17:00-04:00,ENDP,positive
422933.0,Moody's Lowers Endo Health Solutions to Ba3 From Ba2,2013-06-17 16:26:00-04:00,ENDP,positive
422934.0,S&P Downgrades Endo Health Solutions to BB-; Outlook Stable,2013-06-17 15:41:00-04:00,ENDP,positive
422935.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROA,2013-06-17 04:08:00-04:00,ENDP,positive
422936.0,UPDATE: Jefferies Raises PT on Endo Health Following DeSilva Public Appearance,2013-06-07 12:33:00-04:00,ENDP,neutral
422937.0,"Jefferies Maintains Buy on Endo Health Solutions Inc., Raises PT to $45.00",2013-06-07 07:49:00-04:00,ENDP,positive
422938.0,UPDATE: Cantor Fitzgerald Downgrades Endo Health to Sell Following Updated 2013 Guidance,2013-06-06 14:21:00-04:00,ENDP,neutral
422939.0,"UBS Maintains Buy on Endo Health Solutions Inc., Raises PT to $41.00",2013-06-06 10:31:00-04:00,ENDP,positive
422940.0,"UPDATE: Stifel Nicolaus Raises PT on Endo Health Solutions Following Opana ER Setback, Management Reshuffling",2013-06-06 10:12:00-04:00,ENDP,positive
422941.0,"Stifel Nicolaus Maintains Buy on Endo Health Solutions Inc., Raises PT to $40.00",2013-06-06 08:52:00-04:00,ENDP,positive
422942.0,Benzinga's Top Downgrades,2013-06-06 08:29:00-04:00,ENDP,positive
422943.0,Leerink Swann Upgrades Endo Health Solutions Inc. to Outperform,2013-06-06 07:51:00-04:00,ENDP,positive
422944.0,"Cantor Fitzgerald Downgrades Endo Health Solutions Inc. to Sell, Announces $30.00 PT",2013-06-06 06:34:00-04:00,ENDP,positive
422945.0,Endo Health Solutions Announces Actions To Streamline Operations And Expand Platform For Sustainable Cash Flow And Earnings Growth,2013-06-05 16:18:00-04:00,ENDP,positive
422946.0,Endo Health Solutions Inc. Sees FY2013 EPS $4.10-4.40 vs $4.27 Est; Lowers FY2013 Sales Guidance from $2.80B-2.95B to $2.65B-2.80B vs $2.80B Est,2013-06-05 16:17:00-04:00,ENDP,positive
422947.0,"Endo Health Exploring Strategic Alternatives for Healthtronics, Branded Pharma Platform, Expects Fy13 Sales $2.65-2.8B, EPS $4.10-4.40, Cutting 15% of Staff",2013-06-05 16:16:00-04:00,ENDP,negative
422948.0,"Endo Pharma Says FDA Issues CRL on Aveed NDA, Says Didn't Include Request for Added Trials",2013-05-30 16:18:00-04:00,ENDP,neutral
422949.0,"Endo Health Announces CFO, COO to Leave Co.",2013-05-29 09:01:00-04:00,ENDP,negative
422950.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio,2013-05-24 04:04:00-04:00,ENDP,negative
422951.0,"Buckingham Research Upgraded Endo Health Solutions Inc. to Buy, Maintains $41.00 PT",2013-05-16 12:18:00-04:00,ENDP,positive
422952.0,UPDATE: Jefferies Lowers PT on Endo Pharmaceuticals Following FDA Decision,2013-05-13 11:22:00-04:00,ENDP,negative
422953.0,"Jefferies Maintains Buy on Endo Health Solutions Inc., Lowers PT to $37.00",2013-05-13 09:29:00-04:00,ENDP,positive
422954.0,Benzinga's Top Pre-Market Losers,2013-05-13 08:55:00-04:00,ENDP,negative
422955.0,"Stifel Nicolaus Maintains Buy on Endo Health Solutions Inc., Lowers PT to $36.00",2013-05-13 08:55:00-04:00,ENDP,positive
422956.0,Lazard Capital Markets Downgrades Endo Health Solutions Inc. to Sell,2013-05-13 08:24:00-04:00,ENDP,positive
422957.0,Endo Health Solutions Trades Down 2.5% after Resumption of Trade,2013-05-10 17:24:00-04:00,ENDP,positive
422958.0,PREVIEW: Endo Health Solutions to Resume Trading at 5:20 PM ET,2013-05-10 17:12:00-04:00,ENDP,positive
422959.0,Endo Health Halted Again,2013-05-10 15:41:00-04:00,ENDP,neutral
422960.0,Endo Health Solutions Halted Again; Pending News,2013-05-10 15:41:00-04:00,ENDP,positive
422961.0,Endo Loses Bid to Stop Sales of Generic Painkiller Competition,2013-05-10 15:36:00-04:00,ENDP,negative
422962.0,Endo Health Trading Off Lows Following Circuit Breaker Halt as FDA Denies Petition to Block Generic Opana ER,2013-05-10 15:29:00-04:00,ENDP,negative
422963.0,Endo Health Solutions Halted; Pending News,2013-05-10 15:23:00-04:00,ENDP,positive
422964.0,UPDATE: Jefferies Raises PT on Endo Health Solutions on Greater Visibility,2013-05-09 12:03:00-04:00,ENDP,positive
422965.0,Buckingham Research Downgrades Endo Health Solutions Inc. to Neutral,2013-05-08 08:37:00-04:00,ENDP,positive
422966.0,Cowen & Company Downgrades Endo Health Solutions Inc. to Underperform,2013-05-08 08:30:00-04:00,ENDP,positive
422967.0,"Endo Health Solutions Inc. Reports Q1 EPS of $1.09, Inline; Revenue of $708.50M vs $738.60M Est; Reaffirms FY Adj. EPS, Sales Guidance, Cuts GAAP EPS Outlook from $2.22-2.52 to $2.10-2.40",2013-05-07 07:24:00-04:00,ENDP,negative
422968.0,Illumina and Other Bargain Biotech Stocks Worth a Look Now,2013-05-01 12:57:00-04:00,ENDP,positive
422969.0,FDA Panel Votes 9-9 on Safety of Endo Pharma's Aveed Testosterone Shot,2013-04-18 15:03:00-04:00,ENDP,positive
422970.0,"Depomed Filed Complaint in NJ Court vs Endo Pharma, Alleges Infringement of Opana ER Patent",2013-04-17 17:01:00-04:00,ENDP,negative
422971.0,UPDATE: Jefferies Raises PT on Endo Health Solutions on FDA OxyContin Block,2013-04-17 11:22:00-04:00,ENDP,negative
422972.0,Benzinga's Top Pre-Market Gainers,2013-04-17 08:48:00-04:00,ENDP,positive
422973.0,"Jefferies Maintains Buy on Endo Health Solutions Inc., Raises PT to $44.00",2013-04-17 08:04:00-04:00,ENDP,positive
422974.0,Traders Attributing Upside in Endo Health Towards End of Day to Report FDA Says Won't Approve Generic Copies of Old OxyContin,2013-04-16 16:22:00-04:00,ENDP,neutral
422975.0,Endo Health Spikes Higher,2013-04-16 14:24:00-04:00,ENDP,neutral
422976.0,"Janney Capital Initiates Coverage on Endo Health Solutions Inc. at Neutral, Announces $34.00 PT",2013-04-10 16:32:00-04:00,ENDP,positive
422977.0,Standpoint Research Downgrades Endo Health Solutions Inc. to Hold,2013-04-10 09:39:00-04:00,ENDP,positive
422978.0,Endo Health Shares Continue to Rise as Traders Passing Around Bullish Seeking Alpha Article,2013-04-03 13:00:00-04:00,ENDP,positive
422979.0,"Bank of America Reiterates Buy Rating, $33 PT on Endo Health Solutions on Updated Scenario Analysis",2013-03-18 11:59:00-04:00,ENDP,positive
422980.0,Moody's Lowers Outlook on Endo Health Solutions to Negative,2013-03-04 11:52:00-05:00,ENDP,negative
422981.0,Endo Health Solutions Inc. Reports Q4 EPS of $1.62 vs $1.55 Est; Revenue of $801.10M vs $808.23M Est,2013-02-28 16:07:00-05:00,ENDP,positive
422982.0,"Earnings Scheduled For February 28, 2013",2013-02-28 04:36:00-05:00,ENDP,neutral
422983.0,"Mid-Afternoon Market Update: Markets Head Down Sharply, Barnes & Noble Remains Up",2013-02-25 16:01:00-05:00,ENDP,positive
422984.0,"Mid-Day Market Update: Markets Turn Red, Dillard's Tumble On Downbeat Results",2013-02-25 12:35:00-05:00,ENDP,neutral
422985.0,"Endo Health Says Holveck Retiring, Names Rajiv De Silva President, CEO Endo Health Solutions",2013-02-25 08:33:00-05:00,ENDP,positive
422986.0,UPDATE: Piper Jaffray Downgrades Endo Pharmaceuticals to Underweight; More Downside Possible,2013-02-25 07:53:00-05:00,ENDP,negative
422987.0,"Piper Jaffray Downgrades Endo Health Solutions Inc. to Underweight, Lowers PT to $22.00",2013-02-25 06:14:00-05:00,ENDP,positive
422988.0,Endo Health Solutions Shares Down Nearly 4% Following Downgrade to Underperform at RBC,2013-02-07 11:37:00-05:00,ENDP,positive
422989.0,Endo Health Spikes Lower on Cautious Deal Reporter Comments,2013-02-05 15:18:00-05:00,ENDP,negative
422990.0,Bloomberg Reporting Fidelity Said to Urge Endo Health to Consider Selling Itself,2013-02-04 17:42:00-05:00,ENDP,neutral
422991.0,Oppenheimer Downgraded Endo Health Solutions Inc. to Market Perform,2013-01-31 10:35:00-05:00,ENDP,positive
422992.0,Endo Pharmaceuticals has Everybody Interested as M&A Target,2013-01-31 09:06:00-05:00,ENDP,positive
422993.0,"Benzinga's M&A Chatter for Wednesday January 30, 2013",2013-01-30 19:03:00-05:00,ENDP,neutral
422994.0,Valeant Pharmaceuticals Spokesperson Declines Comment on Report of Possible Bid for Endo Health,2013-01-30 15:45:00-05:00,ENDP,neutral
422995.0,Editor of Little Bear Blog is Short Endo Health,2013-01-30 15:23:00-05:00,ENDP,neutral
422996.0,"Mid-Afternoon Market Update: RIMM Falls Further, Endo Health Rises on Exploration of a Sale",2013-01-30 15:22:00-05:00,ENDP,positive
422997.0,Hearing UBS Says Endo Likely to be Sold at $40+/share.,2013-01-30 15:15:00-05:00,ENDP,neutral
422998.0,Valeant Pharmaceuticals Spikes Higher on Report they are Interested in Buyimg Endo,2013-01-30 14:37:00-05:00,ENDP,positive
422999.0,"UPDATE: Hearing Warner Chilcott, Valeant Pharma Could Be Considering Bid for Endo Health",2013-01-30 14:37:00-05:00,ENDP,neutral
423000.0,"Endo Health Resumes Following Breaker Halt, Stock Now Up 12%",2013-01-30 14:34:00-05:00,ENDP,neutral
423001.0,Endo Health is in Talks to Sell Itself -Reuters,2013-01-30 14:33:00-05:00,ENDP,neutral
423002.0,Hearing Unconfirmed Chatter Company is for Sale,2013-01-30 14:31:00-05:00,ENDP,negative
423003.0,"Endo Health Halted on Circuit Breaker, Up 6.7%",2013-01-30 14:30:00-05:00,ENDP,neutral
423004.0,Endo Spikes Higher,2013-01-30 14:30:00-05:00,ENDP,neutral
423005.0,"Endo Health, Novartis Mutually Ended Master Development/Toll Pact",2013-01-07 09:00:00-05:00,ENDP,neutral
423006.0,UPDATE: Stifel Nicolaus Cuts PT to $26.50 on Endo Health Solutions on Lower Guidance  ,2013-01-04 13:31:00-05:00,ENDP,negative
423007.0,RBC Says 'Not Enough Clarity on Near-Term Issues Facing' Endo Health; Cuts Target to $25,2013-01-04 12:06:00-05:00,ENDP,negative
423008.0,Stocks Hitting 52-Week Lows,2013-01-04 10:44:00-05:00,ENDP,negative
423009.0,"UPDATE: Piper Jaffray Downgrades Endo Health Solutions to Neutral, Lowers PT",2013-01-04 10:15:00-05:00,ENDP,positive
423010.0,"UBS Maintains Buy on Endo Health Solutions Inc., Lowers PT to $40.00",2013-01-04 10:02:00-05:00,ENDP,positive
423011.0,"Stifel Nicolaus Maintains Buy on Endo Health Solutions Inc., Lowers PT to $38.00",2013-01-04 07:56:00-05:00,ENDP,positive
423012.0,"Piper Jaffray Downgrades Endo Health Solutions Inc. to Neutral, Lowers PT to $28.00",2013-01-04 07:16:00-05:00,ENDP,positive
423013.0,UPDATE: Endo Health Solutions Inc. Sees FY2013 EPS $4.40-4.70 vs $5.08 Est; Sees Sales $2.80B-2.95B vs $3.05B Est,2013-01-03 16:35:00-05:00,ENDP,positive
423014.0,Endo Health Sees FY12 EPS At or Below the Low End of Previously-Issued $5-5.10 Range,2013-01-03 16:35:00-05:00,ENDP,negative
423015.0,UPDATE: JP Morgan Cuts PT to $35 on Endo Health Solutions Ahead of Guidance  ,2012-12-27 12:40:00-05:00,ENDP,positive
423016.0,"JP Morgan Maintains Overweight on Endo Health Solutions Inc., Lowers PT to $35.00",2012-12-27 09:22:00-05:00,ENDP,positive
423017.0,Endo Health Solutions Offers Comment on Dismissal of Suit Against FDA,2012-12-19 17:12:00-05:00,ENDP,positive
423018.0,Endo Health Loses Bid to Stop Sales of Generic Painkiller,2012-12-19 16:33:00-05:00,ENDP,negative
423019.0,Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue,2012-12-19 03:22:00-05:00,ENDP,positive
423020.0,From Earlier: Needham Downgrades Endo Health Solutions Inc. to Underperform,2012-12-14 12:09:00-05:00,ENDP,positive
423021.0,Benzinga's Top Pre-Market Losers,2012-12-13 08:16:00-05:00,ENDP,negative
423022.0,"UPDATE: Endo Health Solutions Announces CEO Transition Plan; Won't Hit FY12, FY13 Guidance",2012-12-12 17:26:00-05:00,ENDP,positive
423023.0,"Endo Health Solutions Launches 7.5mg, 15mg Strengths of Reformulated, Crush-Resistant OPANA ER",2012-12-11 12:57:00-05:00,ENDP,positive
423024.0,UPDATE: Stifel Nicolaus Cuts PT to $40 on Endo Health Solutions on Competitive Headwinds  ,2012-12-10 11:07:00-05:00,ENDP,positive
423025.0,Endo Health Solutions Confirms FDA Suit Related to Non-Tamper Resistant Oxymorphone,2012-11-30 15:29:00-05:00,ENDP,positive
423026.0,Endo Health Unit Sues FDA to Block Sales of Generic Opana; Co. Says Original Opana Can Be Inhaled by Drug Abusers,2012-11-30 14:34:00-05:00,ENDP,negative
423027.0,Endo Health Solutions Expecting Q4 EPS $1.58-1.68 vs $1.60 Est,2012-11-15 14:55:00-05:00,ENDP,positive
423028.0,Endo Health Offers Prelim. Data Showing 59% Drop in Abuse of Reformulated OPANA ER,2012-11-13 15:20:00-05:00,ENDP,negative
423029.0,"UBS Maintains Endo Pharmaceuticals Holdings at Buy, Lowers PT from $45 to $42",2012-11-06 10:35:00-05:00,ENDP,negative
423030.0,"Jefferies & Company Maintains Endo Pharmaceuticals Holdings at Buy, Lowers PT from $42 to $36",2012-11-06 07:42:00-05:00,ENDP,negative
423031.0,"Oppenheimer Maintains Endo Pharmaceuticals Holdings at Outperform, Lowers PT from $42 to $36",2012-11-05 15:38:00-05:00,ENDP,negative
423032.0,"UPDATE: Piper Jaffray Reiterates Overweight Rating, Lowers PT on Endo Health Solutions",2012-10-05 11:18:00-04:00,ENDP,negative
423033.0,"UPDATE: Oppenheimer Holdings Reiterates Outperform Rating, Lowers PT on Endo Health Solutions",2012-10-05 10:56:00-04:00,ENDP,positive
423034.0,"JP Morgan Maintains Endo Pharmaceuticals Holdings at Overweight, Lowers PT from $45 to $42",2012-10-05 10:39:00-04:00,ENDP,negative
423035.0,"UBS Maintains Endo Pharmaceuticals Holdings at Buy, Lowers PT from $50 to $45",2012-10-05 10:26:00-04:00,ENDP,negative
423036.0,RBC Capital  Downgraded Endo Pharmaceuticals Holdings from Outperform to Sector Perform,2012-10-05 09:21:00-04:00,ENDP,neutral
423037.0,Benzinga's Top Downgrades,2012-10-05 07:37:00-04:00,ENDP,positive
423038.0,"Piper Jaffray Maintains Endo Pharmaceuticals Holdings at Overweight, Lowers PT from $45 to $44",2012-10-05 07:04:00-04:00,ENDP,negative
423039.0,"Oppenheimer Maintains Endo Pharmaceuticals Holdings at Outperform, Lowers PT from $46 to $42",2012-10-05 06:54:00-04:00,ENDP,negative
423040.0,From Earlier: Endo Health Guides FY13 Revenue $3-3.2B vs $3.22B Est; Guides FY13 EPS $5.20-5.40 vs $5.51 Est,2012-10-04 09:50:00-04:00,ENDP,neutral
423041.0,Endo Health Guides Q3 EPS $1.25 vs $1.36 Est.,2012-10-04 07:27:00-04:00,ENDP,neutral
423042.0,Endo Health Solutions Spikes Higher,2012-10-03 10:54:00-04:00,ENDP,positive
423043.0,Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA® ER,2012-09-26 16:11:00-04:00,ENDP,positive
423044.0,"Stifel Nicolaus Maintains Endo Pharmaceuticals Holdings at Buy, Lowers PT from $50 to $44",2012-09-25 08:01:00-04:00,ENDP,negative
423045.0,Endo Pharmaceuticals Added to US 1 List at Bank of America,2012-09-10 06:30:00-04:00,ENDP,neutral
423046.0,"J.P. Morgan Reiterates Overweight Rating, $48 PT on Endo Health Solutions",2012-08-24 10:37:00-04:00,ENDP,negative
423047.0,Statement on FDA Decision Regarding Endo Citizen Petition and Approval of a Generic Formulation of LIDODERM® ,2012-08-23 20:09:00-04:00,ENDP,positive
423048.0,"Jefferies & Company Maintains Endo Pharmaceuticals Holdings at Buy, Lowers PT from $48 to $42",2012-08-08 06:20:00-04:00,ENDP,negative
